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SCIENTIFIC OPINION 
Scientific Opinion on Dietary Reference Values for vitamin A
1
 
EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA)
2,3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies 
derived Dietary Reference Values for vitamin A. The Panel considered that a concentration of 20 µg retinol/g 
liver can be used as a target for establishing the Average Requirement (AR) for vitamin A. In the absence of a 
better characterisation of the relationship between vitamin A intake and liver stores, a factorial approach was 
applied. This approach considered a total body/liver retinol store ratio of 1.25, a liver/body weight ratio of 2.4 %, 
a fractional catabolic rate of body retinol of 0.7 % per day, an efficiency of storage in the whole body for 
ingested retinol of 50 % and reference weights for women and men in the EU of 58.5 and 68.1 kg, respectively. 
ARs of 570 µg retinol equivalent (RE)/day for men and 490 µg RE/day for women were derived. Assuming a 
coefficient of variation (CV) of 15 %, Population Reference Intakes (PRIs) of 750 µg RE/day for men and 
650 µg RE/day for women were set. For infants aged 7–11 months and children, the same equation as for adults 
was applied by using specific values for reference weight and liver/body weight ratio. For catabolic rate, the 
adult value corrected on the basis of a growth factor was used. ARs range from 190 µg RE/day in infants aged 7–
11 months to 580 µg RE/day in boys aged 15–17 years. PRIs for infants and children were estimated using a CV 
of 15 % and range from 250 to 750 µg RE/day. For pregnancy and lactation, additional vitamin A requirements 
related to the accumulation of retinol in fetal and maternal tissues and transfer of retinol into breast milk were 
considered and PRIs of 700 and 1 300 µg RE/day, respectively, were set. 
© European Food Safety Authority, 2015 
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SUMMARY 
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition 
and Allergies (NDA) was asked to deliver a scientific opinion on Dietary Reference Values (DRVs) 
for the European population, including vitamin A.  
Vitamin A is a fat-soluble vitamin obtained from the diet either as preformed vitamin A (mainly 
retinol and retinyl esters) in foods of animal origin or as provitamin A carotenoids in plant-derived 
foods. The term vitamin A comprises all-trans-retinol (also called retinol) and the family of naturally 
occurring molecules associated with the biological activity of retinol (such as retinal, retinoic acid, 
retinyl esters), as well as provitamin A carotenoids that are dietary precursors of retinol. The 
biological value of substances with vitamin A activity is expressed as retinol equivalent (RE). Specific 
carotenoids/retinol equivalency ratios are defined for provitamin A carotenoids, which account for the 
less efficient absorption of carotenoids and their bioconversion to retinol. On the basis of available 
evidence, the Panel decided to maintain the conversion factors proposed by the Scientific Committee 
for Food (SCF) for the European populations, namely 1 μg RE equals 1 μg of retinol, 6 μg of β-
carotene and 12 μg of other provitamin A carotenoids. Vitamin A requirement can be met with any 
mixture of preformed vitamin A and provitamin A carotenoids that provides an amount of vitamin A 
equivalent to the reference value in terms of µg RE/day. 
Vitamin A is involved in vision as retinal, which plays a central role in the mechanisms of photo-
transduction, and in the systemic maintenance of the growth and integrity of cells in body tissues 
through the action of retinoic acid, which acts as regulator of genomic expression. The most specific 
clinical consequence of vitamin A deficiency is xerophthalmia, which encompasses a clinical 
spectrum of ocular manifestations. In low-income countries, vitamin A deficiency in young infants 
and children has been associated with increased infectious morbidity and mortality, including 
respiratory infection and diarrhoea.  
Preformed vitamin A is efficiently absorbed (70–90 %). The absorption of β-carotene appears to be 
highly variable (5–65 %), depending on food- and diet-related factors, genetic characteristics and the 
health status of the subject. The intestine is the primary tissue where dietary provitamin A carotenoids 
are converted to retinol. Retinol, in the form of retinyl esters, and provitamin A carotenoids enter the 
body as a component of nascent chylomicrons secreted into the lymphatic system. Most dietary retinol 
(in chylomicrons and chylomicron remnants) is taken up by the liver, which is the major site of retinol 
metabolism and storage. Hepatic retinyl esters are hydrolysed to free retinol, and delivered to tissues 
by retinol-binding protein. The efficiency of storage and catabolism of retinol depends on vitamin A 
status. Low retinol stores are associated with a reduced efficiency of storage and decreased absolute 
catabolic rate. The majority of retinol metabolites are excreted in urine, in faeces via bile and to a 
lesser extent in breath. 
Vitamin A status is best expressed in terms of total body store of retinol (i.e. as free retinol and retinyl 
esters) or, alternatively, as liver concentration of the vitamin. A concentration of 20 µg retinol/g liver 
(0.07 µmol/g) in adults represents a level assumed to maintain adequate plasma retinol concentration, 
to prevent clinical signs of deficiency and to provide adequate stores. The Panel considered that this 
can be used as a target value for establishing the Average Requirement (AR) for vitamin A for all age 
groups. The relationship between dietary intake of vitamin A and retinol liver stores has been explored 
with stable isotope dilution methods but available data are considered insufficient to derive an AR. A 
factorial approach was applied. This approach considered a total body/liver retinol store ratio of 1.25 
(i.e. 80 % of retinol body stores are in the liver), a liver/body weight ratio of 2.4 %, a fractional 
catabolic rate of retinol of 0.7 % per day of total body stores, an efficiency of storage in the whole 
body of ingested retinol of 50 % and the reference body weights for women and men in the EU of 58.5 
and 68.1 kg, respectively. On the basis of this approach, ARs of 570 µg RE/day for men and 
490 µg RE/day for women were derived after rounding. Assuming a coefficient of variation (CV) of 
15 % because of the variability in requirement and the large uncertainties in the dataset, Population 
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Reference Intakes (PRIs) of 750 µg RE/day for men and 650 µg RE/day for women were set after 
rounding. 
For infants aged 7–11 months and children, the same target concentration of retinol in the liver and the 
same equation as for adults was used to calculate ARs. Specific values for reference body weight and 
for liver/body weight ratio were used. There are some indications that retinol catabolic rate may be 
higher in children than in adults, but data are limited. The Panel decided to apply the value for 
catabolic rate in adults and correct it on the basis of a growth factor. Estimated ARs range from 
190 µg RE/day in infants aged 7–11 months to 580 µg RE/day in boys aged 15–17 years. PRIs for 
infants and children were estimated based on a CV of 15 % and range from 250 to 750 µg RE/day. 
For pregnant women, the Panel assumed that a total amount of 3 600 µg retinol is accumulated in the 
fetus over the course of pregnancy. Considering that the accretion mostly occurs in the last months of 
pregnancy, and assuming an efficiency of storage of 50 % for the fetus, an additional daily 
requirement of 51 µg RE was calculated for the second half of pregnancy. In order to allow for the 
extra need related to the growth of maternal tissues, the Panel applied this additional requirement to 
the whole period of pregnancy. Consequently, an AR of 540 µg RE/day was estimated for pregnant 
women. Considering a CV of 15 % and rounding, a PRI of 700 µg RE/day was derived for pregnant 
women. 
For lactating women, an increase in the AR was based on the vitamin A intake required to compensate 
for the loss of retinol in breast milk. Based on an average amount of retinol secreted in breast milk of 
424 μg/day and an absorption efficiency of retinol of 80 %, an additional vitamin A intake 
of 530 µg RE/day was considered sufficient to replace these losses. An AR of 1 020 μg RE/day was 
estimated and, considering a CV of 15 % and rounding down, a PRI of 1 300 μg RE/day was proposed 
for lactating women. 
Foods rich in retinol include offal and meat, butter, retinol-enriched margarine, dairy products and 
eggs, while foods rich in β-carotene include vegetables and fruits, such as sweet potatoes, carrots, 
pumpkins, dark green leafy vegetables, sweet red peppers, mangoes and melons. On the basis of data 
from 12 dietary surveys in nine EU countries, vitamin A intake was assessed using food consumption 
data from the EFSA Comprehensive Food Consumption Database and vitamin A composition data 
from the EFSA nutrient composition database. Average vitamin A intake ranged between 409 and 
651 μg RE/day in children aged 1 to < 3 years, between 607 and 889 μg RE/day in children aged 3 to 
< 10 years, between 597 and 1 078 μg RE/day in children aged 10 to < 18 years and between 816 and 
1 498 μg RE/day in adults. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The scientific advice on nutrient intakes is important as the basis of Community action in the field of 
nutrition, for example such advice has in the past been used as the basis of nutrition labelling. The 
Scientific Committee for Food (SCF) report on nutrient and energy intakes for the European 
Community dates from 1993. There is a need to review and, if necessary, to update these earlier 
recommendations to ensure that the Community action in the area of nutrition is underpinned by the 
latest scientific advice.  
In 1993, the SCF adopted an opinion on the nutrient and energy intakes for the European Community.
4
 
The report provided Reference Intakes for energy, certain macronutrients and micronutrients, but it did 
not include certain substances of physiological importance, for example dietary fibre. 
Since then new scientific data have become available for some of the nutrients, and scientific advisory 
bodies in many European Union Member States and in the United States have reported on 
recommended dietary intakes. For a number of nutrients these newly established (national) 
recommendations differ from the reference intakes in the SCF (1993) report. Although there is 
considerable consensus between these newly derived (national) recommendations, differing opinions 
remain on some of the recommendations. Therefore, there is a need to review the existing EU 
Reference Intakes in the light of new scientific evidence, and taking into account the more recently 
reported national recommendations. There is also a need to include dietary components that were not 
covered in the SCF opinion of 1993, such as dietary fibre, and to consider whether it might be 
appropriate to establish reference intakes for other (essential) substances with a physiological effect. 
In this context, EFSA is requested to consider the existing Population Reference Intakes for energy, 
micro- and macronutrients and certain other dietary components, to review and complete the SCF 
recommendations, in the light of new evidence, and in addition advise on a Population Reference 
Intake for dietary fibre.  
For communication of nutrition and healthy eating messages to the public it is generally more 
appropriate to express recommendations for the intake of individual nutrients or substances in food-
based terms. In this context, EFSA is asked to provide assistance on the translation of nutrient based 
recommendations for a healthy diet into food based recommendations intended for the population as a 
whole.  
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Article 29(1)(a) and Article 31 of Regulation (EC) No 178/2002,
5
 the Commission 
requests EFSA to review the existing advice of the Scientific Committee for Food on population 
reference intakes for energy, nutrients and other substances with a nutritional or physiological effect in 
the context of a balanced diet which, when part of an overall healthy lifestyle, contribute to good 
health through optimal nutrition.  
In the first instance, EFSA is asked to provide advice on energy, macronutrients and dietary fibre. 
Specifically advice is requested on the following dietary components:  
 Carbohydrates, including sugars; 
 Fats, including saturated fatty acids, polyunsaturated fatty acids and monounsaturated fatty 
acids, trans fatty acids; 
                                                     
4  Scientific Committee for Food, Nutrient and energy intakes for the European Community, Reports of the Scientific 
Committee for Food 31st series, Office for Official Publication of the European Communities, Luxembourg, 1993. 
5  Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general 
principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in 
matters of food safety. OJ L 31, 1.2.2002, p. 1–24. 
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 Protein; 
 Dietary fibre. 
Following on from the first part of the task, EFSA is asked to advise on population reference intakes 
of micronutrients in the diet and, if considered appropriate, other essential substances with a 
nutritional or physiological effect in the context of a balanced diet which, when part of an overall 
healthy lifestyle, contribute to good health through optimal nutrition. 
Finally, EFSA is asked to provide guidance on the translation of nutrient based dietary advice into 
guidance, intended for the European population as a whole, on the contribution of different foods or 
categories of foods to an overall diet that would help to maintain good health through optimal nutrition 
(food-based dietary guidelines). 
Dietary Reference Values for vitamin A 
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ASSESSMENT 
1. Introduction 
In 1993, the Scientific Committee for Food (SCF) adopted an opinion on nutrient and energy intakes 
for the European Community and derived Average Requirements (ARs) and Population Reference 
Intakes (PRIs) for vitamin A for men and women. Specific PRIs were set for pregnant and lactating 
women. PRIs for infants aged 7–11 months and children were also proposed.  Vitamin A is a fat-
soluble vitamin obtained from the diet either as preformed vitamin A (mainly retinol and retinyl 
esters) in foods of animal origin, or as provitamin A carotenoids in plant-derived foods (Figure 1). The 
purpose of this opinion is to review Dietary Reference Values (DRVs) for vitamin A. The Panel notes 
that possible functions of carotenoids other than as dietary precursors of retinol, and evidence for a 
requirement for carotenoids as such, have been reviewed by the SCF (1993) and other authoritative 
bodies (DH, 1991; IOM, 2001; WHO/FAO, 2004; D-A-CH, 2013). This is out of the scope of the 
present opinion. 
2. Definition/category 
2.1. Chemistry 
The term vitamin A comprises all-trans-retinol (also called retinol) and the family of naturally 
occurring molecules associated with the biological activity of retinol (such as retinal, retinoic acid and 
retinyl esters), as well as the group of provitamin A carotenoids (such as β-carotene, α-carotene and β-
cryptoxanthin) that are dietary precursors of retinol (Figure 1).  
Figure 1: Structure of the naturally occurring forms of vitamin A: all-trans-retinol, an all-trans-
retinyl ester (R=alkyl chain), all-trans-retinal, the active metabolites all-trans-retinoic acid 
(transcriptionally active) and 11-cis-retinal (active in vision), and the major provitamin A carotenoid, 
all-trans-β-carotene.  
Retinol is composed of a β-ionone ring, a polyunsaturated side chain and a polar end group (molecular 
mass 286.5 Da) (Figure 1). This chemical structure makes it poorly soluble in water but easily 
transferable through membrane lipid bilayers. Preformed vitamin A consists predominantly of retinol 
and retinyl esters, which are supplied in the diet by animal-derived products. The term retinoids refers 
Dietary Reference Values for vitamin A 
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to retinol and structurally related compounds, including its metabolites (retinyl ester, retinal and 
retinoic acid), and synthetic analogues (Anonymous, 1983).  
Retinol and retinyl esters are the most abundant forms of vitamin A in the body. Retinol is a transport 
form and a precursor of the transcriptionally active metabolite all-trans-retinoic acid, and retinyl esters 
are retinol storage forms and serve as substrate for the formation of the visual chromophore 11-cis-
retinal (Al Tanoury et al., 2013). All-trans-retinoic acid can be isomerised through a non-enzymatic 
process to 9-cis- or 13-cis-retinoic acid isomers. The isomer 13-cis-retinoic acid is less 
transcriptionally active than the all-trans and the 9-cis isomers. Other forms of retinol and retinoic 
acid, which include various oxo-, hydroxy- and glucuronide forms, are also present in the body, but at 
very low concentrations relative to retinol and retinyl esters, and probably appear as catabolic products 
for elimination from the body (O'Byrne and Blaner, 2013).  
Carotenoids are isoprenoids that contain up to 15 conjugated double bonds, synthesised in plants and 
microorganisms and occurring naturally in fruits and vegetables. Among them, β-carotene, α-carotene, 
and β-cryptoxanthin are provitamin A carotenoids (Eroglu and Harrison, 2013). To exhibit 
provitamin A activity, the carotenoid molecule must have at least one unsubstituted β-ionone ring and 
the correct number and position of methyl groups in the polyene chain (Wirtz et al., 2001). 
In this opinion, the terms retinol, retinoic acid and carotenoids refer to their all-trans-isomers, unless 
specified otherwise. 
The biological value of substances with vitamin A activity is expressed as retinol equivalent (RE), 
with 1 μg RE equal to 1 μg retinol. Specific carotenoids/retinol equivalency ratios are defined for 
provitamin A carotenoids, which account for the less efficient absorption of carotenoids and their 
bioconversion to retinol (Section 2.3.8). 
2.2. Function of vitamin A 
2.2.1. Biochemical functions 
Vitamin A is an essential nutrient as humans do not have the capability for de novo synthesis of 
compounds with vitamin A activity. Vitamin A is involved in the visual cycle in the retina and the 
systemic maintenance of growth and integrity of cells in body tissues. 
In the eye, the active metabolite 11-cis-retinal works as a visual chromophore involved in 
phototransduction. Visual pigments are G-protein-coupled receptors that mediate phototransduction, 
the process by which light is translated into an electrical (nervous) signal (Palczewski, 2010). In this 
complex pathway, also known as the retinoid cycle, 11-cis-retinal binds opsin to form rhodopsin and 
cone pigments (Wald, 1968). Visual perception starts with the absorption of a photon, which induces 
isomerisation of 11-cis-retinal to 11-trans-retinal. After bleaching, 11-trans-retinal is released from 
opsin and the 11-cis-retinal chromophore is regenerated to sustain vision (von Lintig et al., 2010). In 
addition, all-trans-retinoic acid is also required to maintain normal differentiation of the cornea and 
conjunctival membranes and of the photoreceptor rod and cone cells of the retina (Blomhoff and 
Blomhoff, 2006). 
Retinoic acid is a transcriptionally active metabolite and is thought to account for the regulatory 
properties of vitamin A upon more than 500 different target genes involved in the differentiation and 
development of fetal and adult tissues, stem cell differentiation, apoptosis, support of reproductive and 
immune functions and regulation of lipid metabolism and energy homeostasis (Al Tanoury et al., 
2013; Kedishvili, 2013). Retinoic acid can activate two different types of nuclear receptors, retinoic 
acid receptor (RAR) and peroxisome proliferator-activated receptor (PPAR) β/δ. In the cytosol, 
retinoic acid binds to cellular retinoic acid-binding protein (CRABP) II, and the resulting complex 
channels retinoic acid to RARs. RARs work as heterodimers with retinoic X receptors (RXRs) and 
transduce the retinoic acid signal as ligand-dependent regulators of transcription. Retinoic acid also 
binds to fatty acid-binding protein (FABP) 5 and activates the nuclear translocation of FABP5, which 
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then delivers the ligand to the PPARβ/δ subtype. In addition, retinoic acid has extranuclear, non-
transcriptional effects, such as the activation of the mitogen-activated protein kinase signalling 
pathway, which influences the expression of retinoic acid target genes via phosphorylation processes 
(Al Tanoury et al., 2013).  
The importance of vitamin A in immune function is well established (Stephensen, 2001; Field et al., 
2002). Mechanisms by which vitamin A may modulate the immune system have been studied in vitro 
and in animal models. Retinoic acid stimulates the proliferation of T-lymphoid cells, inhibits the 
proliferation of B-cells and B-cell precursors and exerts an effect on the T-helper (Th) cell balance by 
suppressing Th1 development and enhancing Th2 development. It also enhances macrophage-
mediated inflammation by increasing production of interleukin 12 (IL-12) and interferon-gamma 
(IFN-γ), regulates the antigen presentation by immature dendritic cells, as well as their maturation, and 
impairs the ability of macrophages to ingest and kill bacteria (Ross et al., 2011; Cassani et al., 2012; 
Ross, 2012). Other effects of vitamin A on the immune system are related to apoptotic effects on 
immune-competent cells during down-regulation of immune reactions and during thymic selection and 
to the alteration of genes relevant to the immune response (Ruhl, 2007). 
2.2.2. Health consequences of deficiency and excess 
2.2.2.1. Deficiency 
The main symptoms observed in case of deficiency of vitamin A are intrauterine and post-natal growth 
retardation and a large array of congenital malformations collectively referred to as the fetal “vitamin 
A deficiency syndrome”, which is well documented in animals (Clagett-Dame and Knutson, 2011). In 
adults, vitamin A deficiency adversely affects several functions, such as vision, immunity, and 
reproduction, and has been related to the worsening of low iron status, resulting in vitamin A 
deficiency anaemia (Ross, 2014).  
The most specific clinical consequence of vitamin A deficiency is xerophthalmia, which encompasses 
the clinical spectrum of ocular manifestations of vitamin A deficiency. It includes night blindness 
(nyctalopia), due to impaired dark adaptation because of slow regeneration of rhodopsin, early 
keratinising metaplasia (Bitot’s spots), impaired production of tears, conjunctival xerosis, corneal 
xerosis, and corneal ulceration and scarring, which may result in blindness (WHO, 1982, 1996, 2009). 
Night blindness, the first ocular symptom of deficiency, responds rapidly to an increase in vitamin A 
intake (Dowling and Gibbons, 1961; Sommer A, 1982; Katz et al., 1995; Christian et al., 1998a). 
Vitamin A deficiency also induces follicular hyperkeratosis, which disappears after retinol or β-
carotene supplementation (Chase et al., 1971; Sauberlich et al., 1974).  
In low-income countries, vitamin A deficiency in young infants and children has been associated with 
increased infectious morbidity and mortality, including respiratory infection and diarrhoea (Mayo-
Wilson et al., 2011).  
2.2.2.2. Excess 
The classical signs and symptoms of acute and chronic hypervitaminosis A comprise skin disorders, 
nausea, vomiting, disorders of the musculo-skeletal system and liver damage (Biesalski, 1989; 
Hathcock et al., 1990). Bulging fontanelle in infants and increased intracranial pressure are also 
classical adverse effects of vitamin A toxicity (Hathcock et al., 1990). The teratogenic effect of 
excessive intake of vitamin A or specific retinoids is well documented, in both animals and humans 
(Hathcock et al., 1990).  
In 2002, the SCF reviewed possible adverse effects of long-term intake of retinol and retinyl esters 
(SCF, 2002). The SCF set a Tolerable Upper Intake Level (UL) for preformed vitamin A of 
3 000 µg RE/day for women of childbearing age and men, based on the risk of hepatotoxicity and 
teratogenicity. The UL was proposed to also apply during pregnancy and lactation. ULs for children 
Dietary Reference Values for vitamin A 
 
EFSA Journal 2015;13(3):4028 11 
were extrapolated from the UL for adults, based on allometric scaling (body weight to the power of 
0.75). ULs were set at 800 µg RE/day for children aged 1–3 years, 1 100 µg RE/day for children aged 
4–6 years, 1 500 µg RE/day for children aged 7–10 years, 2 000 µg RE/day for children aged 11–14 
years and 2 600 µg RE/day for children aged 15–17 years.  
The SCF noted that an increased risk of bone fracture was reported for an intake of 1 500 µg RE/day 
or higher. Presumed mechanisms related to a possible effect of retinoic acid on osteoblasts and 
osteoclasts (Scheven and Hamilton, 1990; Kindmark et al., 1995; Cohen-Tanugi and Forest, 1998) and 
a molecular interaction of vitamin A and vitamin D indicating an antagonism of vitamin A towards the 
action of vitamin D (Rohde et al., 1999; Johansson and Melhus, 2001) were mentioned. Overall, the 
SCF considered that the available data did not provide sufficient evidence of causality, owing to the 
possibility of residual confounding, and were not appropriate for establishing a UL. The SCF noted 
that “because the tolerable upper level may not adequately address the possible risk of bone fracture 
in particularly vulnerable groups, it would be advisable for postmenopausal women, who are at 
greater risk of osteoporosis, to restrict their intake to 1 500 µg RE/day”.  
In a subsequent assessment which considered studies published until 2004, the Scientific Advisory 
Committee on Nutrition (SACN, 2005) concluded that the evidence of an association between high 
intake of retinol and poor bone health was inconsistent. The Committee noted that some 
epidemiological data suggest that a retinol intake of 1 500 μg/day and above is associated with an 
increased risk of bone fracture; the evidence was considered not robust enough to set a Safe Upper 
Level, and a Guidance Level for retinol intake of 1 500 μg/day was set for adults. 
The Panel is aware that additional observational studies on possible associations between retinol and 
vitamin A intake and bone health have been published since the SCF and SACN assessments. The 
Panel notes that different definitions of “vitamin A” have been applied among studies (i.e. defined as 
retinol only, as retinol and provitamin A carotenoids (expressed in IU
6
 or µg RE) or undefined). An 
overview of prospective cohort and nested case–control studies which investigated an association of 
retinol or “vitamin A” intake with the risk of bone fracture is provided in Appendix A. Intervention 
and prospective cohort studies which looked at an association of retinol or “vitamin A” intake with 
markers of bone health are summarised in Appendix B. These appendices tabulate studies considered 
in the SCF and SACN assessments, along with studies published afterwards. Among the latter, no 
association was observed between a cumulative dose of retinol supplementation and the risk of any 
fracture or “osteoporotic fracture” (defined as fractures at the spine, hip, femur, arm, ribs or wrist) in 
2 322 Australian males and females who received 7.5 mg RE/day as retinyl palmitate for 1 to 16 years 
(187 subjects experienced 237 fractures) (Ambrosini et al., 2013). Similarly, no association was found 
between retinol or “vitamin A” intake (from food and supplements) and risk of any fracture or hip 
fracture in the Women’s Health Initiative prospective study, which involved 75 747 postmenopausal 
women in the USA (mean follow-up 6.6 years; 10 405 incident total fractures and 588 hip fractures). 
In contrast, in a stratified analysis, modest increases in total fracture risk with high retinol intake (fifth 
quintile (Q5) = 2 488 µg/day vs. first quintile (Q1) = 348 µg/day) (hazard ratio (HR) = 1.15; 95 % 
confidence interval (CI) 1.03–1.29; p for trend = 0.056) and high “vitamin A” intake 
(Q5 = 8 902 µg RE/day vs. Q1 = 4 445 µg RE/day) (HR = 1.19; 95 % CI 1.04–1.37; p for 
trend = 0.022) were observed in the women with a vitamin D intake ≤ 11 µg/day (Caire-Juvera et al., 
2009). No association between retinol or “vitamin A” intake (from food only or food and supplements) 
and fracture risk was found in a nested case–control analysis of the Danish Osteoporosis Prevention 
Study which involved 1 141 perimenopausal women (163 cases, 978 controls) (Rejnmark et al., 2004). 
Two studies investigated bone mineral density (BMD) as an endpoint. No significant association was 
observed between BMD change and retinol or “vitamin A” intake (from food and supplements) in 891 
women followed for five to seven years in the Aberdeen Prospective Osteoporosis Study (Macdonald 
et al., 2004). No association between retinol or “vitamin A” intake (from food only or food and 
                                                     
6 1 IU = 0.3 µg retinol = 0.6 µg -carotene = 1.2 µg other total mixed carotenoids with vitamin A activity (US DH/FAO, 
1968). 
Dietary Reference Values for vitamin A 
 
EFSA Journal 2015;13(3):4028 12 
supplements) and BMD or change in BMD after a five-year follow-up was found in the Danish 
Osteoporosis Prevention Study, which involved 1 694 women (Rejnmark et al., 2004).  
The Panel is aware of other studies which investigated the association between serum/plasma retinol 
concentration and fracture risk (Opotowsky and Bilezikian, 2004; Ambrosini et al., 2014). Although 
serum/plasma retinol concentration has been used as a biomarker of intake, serum/plasma retinol 
concentration is under homeostatic control and, in the usual range, is not related to observed levels of 
habitual vitamin A intake. Therefore, it is not considered a reliable marker of vitamin A or retinol 
intake (Section 2.4.2).  
The Panel considers that evaluation of the data published since the SCF assessment does not change 
the conclusion of the Panel from that of the SCF with respect to the association between retinol or 
vitamin A intake and risk of bone fracture in postmenopausal women. One prospective cohort study 
indicated a possible interaction between vitamin D intake (< 11 µg/day) and retinol intake in relation 
to the risk of bone fracture in postmenopausal women.  
The Panel is aware of other studies which looked at possible associations between preformed vitamin 
A intake or blood retinol concentration and adverse health outcomes (Grotto et al., 2003; Bjelakovic et 
al., 2008; Chen et al., 2008; Mayo-Wilson et al., 2011; Beydoun et al., 2012; Bjelakovic et al., 2012; 
Bjelakovic et al., 2013; Field et al., 2013; Bjelakovic et al., 2014). Available data on individual 
outcomes are limited or relate to interventions that used large doses of retinol (≥ 6 000 µg) once or 
several times a year, which are difficult to relate to a potential effect of daily dietary intake of retinol. 
2.3. Physiology and metabolism 
The different forms of vitamin A undergo a complex metabolic fate with an exchange between the 
intestine, the plasma, the liver and other peripheral tissues (Figure 2).  
 
Figure 2: Vitamin A forms and metabolic fates.  
2.3.1. Intestinal absorption 
The key digestive processes that occur within the lumen of the intestine include the release of 
preformed vitamin A and provitamin A carotenoids from the food matrix and their emulsification with 
dietary fatty acids and bile acids (Parker, 1996). The presence of dietary fat in the intestine usually 
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increases intestinal absorption of preformed vitamin A and provitamin A carotenoids by enhancing the 
secretion of pancreatic enzymes and of bile salts that provide components (lysophospholipids, 
monoglycerides, free fatty acids) to form luminal mixed micelles of lipids and for intracellular 
assembly of chylomicrons (Roels et al., 1958; Roels et al., 1963; Reddy and Srikantia, 1966; Figueira 
et al., 1969; Jayarajan et al., 1980; Borel et al., 1997; Jalal et al., 1998; Li and Tso, 2003; Unlu et al., 
2005). 
2.3.1.1. Absorption of preformed vitamin A 
Preformed vitamin A is efficiently absorbed in the intestine, in the range of 70–90 % (Reddy and 
Sivakumar, 1972; Sivakumar and Reddy, 1972; Kusin et al., 1974). Almost complete absorption was 
observed in five healthy Indian children administered 1 000 µg retinyl acetate in oil (Sivakumar and 
Reddy, 1972). Absorption remains high even if the amount of ingested preformed vitamin A increases 
(Olson, 1972). A fractional absorption of around 70 % was observed in Indian children when a single 
high dose of retinyl acetate (60 000 µg) was administered (Reddy and Sivakumar, 1972; Kusin et al., 
1974). Quantitative data on the absorption of preformed vitamin A from the diet are scarce. 
Dietary retinyl esters are unable to enter the intestinal mucosa and must first be hydrolysed by retinyl 
ester hydrolases to yield free retinol (Harrison, 2012). Retinyl esters can be hydrolysed within the 
intestinal lumen by non-specific pancreatic enzymes, such as pancreatic triglyceride lipase and 
cholesteryl ester hydrolase, or at the mucosal cell surface by a brush border retinyl ester hydrolase 
(Erlanson and Borgstrom, 1968; Rigtrup and Ong, 1992; Rigtrup et al., 1994; van Bennekum et al., 
2000; Reboul et al., 2006).  
Free retinol is taken up into the intestinal cells by protein-mediated facilitated diffusion and passive 
diffusion mechanisms via the action of membrane-bound lipid transporters involved in fatty acid and 
cholesterol uptake. These include scavenger receptor class B, type 1 (SR-B1), CD36, NPC1L1 and a 
variety of ABC transporters (Hollander and Muralidhara, 1977; Hollander, 1981; Glatz et al., 1997; 
Abumrad et al., 1998; van Heek et al., 2001; Turley and Dietschy, 2003; Wang, 2003; Altmann et al., 
2004; Davis et al., 2004; Nieland et al., 2004; During et al., 2005; Iqbal and Hussain, 2009). Free 
retinol then binds to specific cytoplasmic retinol-binding proteins (RBPs), i.e. the cellular retinol-
binding proteins CRBPI and CRBPII (Ong, 1994). CRBPII is present at high concentrations in the 
enterocytes and appears to be uniquely suited for retinol absorption by the intestine (Herr and Ong, 
1992; Ong, 1994; Li and Norris, 1996; Newcomer et al., 1998).  
CRBP-bound retinol undergoes esterification with long-chain fatty acids, particularly with palmitic 
acid, catalysed mainly (about 90 %) by lecithin:retinol acyltransferase (LRAT), and to a lesser extent 
by the intestinal acyl-CoA:retinol acyltransferase (DGAT1) (Huang and Goodman, 1965; MacDonald 
and Ong, 1988; O'Byrne et al., 2005; Harrison, 2012). The resulting retinyl esters are then packed, 
along with dietary fat and cholesterol, into nascent chylomicrons, which are secreted into the 
lymphatic system for delivery to the blood (Olson, 1989; Blomhoff et al., 1991; Parker, 1996; 
Harrison, 2012). 
2.3.1.2. Absorption of provitamin A carotenoids 
Dietary provitamin A carotenoids are absorbed via passive diffusion or taken up by the enterocyte 
through facilitated transport via SR-B1 (van Bennekum et al., 2005; During and Harrison, 2007; 
Moussa et al., 2008; Harrison, 2012; von Lintig, 2012).  
Once inside the enterocyte, the major part (more than 60 %) of the absorbed provitamin A carotenoids 
are cleaved at their central double bond (15,15′) by β,β-carotene-15,15′-monooxygenase 1 (BCMO1) 
into all-trans-retinal (Devery and Milborrow, 1994; Nagao et al., 1996; Lindqvist and Andersson, 
2002). All-trans-retinal binds to CRBPII, is incorporated intact with dietary fat and cholesterol into 
nascent chylomicrons, or is further oxidised irreversibly to retinoic acid or reduced reversibly to 
retinol (Harrison, 2012).  
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Less than 40 % of absorbed provitamin A carotenoids are not cleaved in the intestine (Castenmiller 
and West, 1998) and are absorbed intact. Along with other lipid-soluble compounds, they are 
incorporated into chylomicrons for transport to the liver and other tissues and are found associated 
with circulating lipoproteins (Johnson and Russell, 1992). The Panel notes that, because of 
physiological differences in provitamin A carotenoid absorption between rodents and humans, rodents 
are not good animal models for studying human carotenoid absorption (Huang and Goodman, 1965). 
Overall, the absorption of β-carotene appears to be highly variable (5–65 %), depending on food- and 
diet-related factors, genetic characteristics and the health status of the subject (Haskell, 2012). This 
has significant implications on the bioequivalence of β-carotene to retinol (Section 2.3.8). Quantitative 
data on absorption of the other provitamin A carotenoids, α-carotene and β-cryptoxanthin, are more 
limited. 
2.3.2. Transport in blood 
A number of different forms of vitamin A are found in the circulation, and these differ in the fasting 
and postprandial states (O'Byrne and Blaner, 2013). They include retinyl esters in chylomicrons, 
chylomicron remnants, very low-density lipoprotein (VLDL), low-density lipoprotein (LDL) and high-
density lipoprotein (HDL); retinol bound to retinol-binding protein (RBP4); retinoic acid bound to 
albumin; and the water-soluble β-glucuronides of retinol and retinoic acid. Provitamin A carotenoids 
may be absorbed intact by the intestine (Section 2.3.1) and can be found in the blood bound to 
chylomicrons and their remnants, VLDL, LDL and HDL (Redlich et al., 1996; Redlich et al., 1999). 
LDL is the major carrier of β-carotene in the plasma of fasting individuals (Romanchik et al., 1995). 
Approximately two-thirds of absorbed retinol is delivered to the blood via the lymph in esterified form 
as retinyl palmitate and other retinyl esters present in chylomicrons. Around one-third is secreted 
directly into the portal circulation, probably as free retinol (Blomhoff et al., 1990; Blomhoff et al., 
1991; Kane and Havel, 1995; Lemieux et al., 1998; Nayak et al., 2001).  
Mean fasting concentration of retinyl esters has been reported to range from 10 to 40 µg/L in adults 
(Bankson et al., 1986; Hartmann et al., 2001). In the postprandial circulation, the concentration of 
retinyl esters increases. Following consumption of a retinol-rich meal (~1–1.5 mg/kg body weight), 
mean retinyl palmitate concentration in plasma was observed to reach 7–9 μmol/L in male volunteers 
(Arnhold et al., 1996; Relas et al., 2000). 
In the fasting circulation, retinol bound to RBP4 is the predominant form of retinoids, with 
concentrations ranging from 2–4 μmol/L in adults from Western countries (Chuwers et al., 1997; 
Hartmann et al., 2001). The retinol–RBP4 complex binds another plasma protein, transthyretin, which 
stabilises the complex and reduces renal filtration of retinol (van Bennekum et al., 2001).  
Retinoic acid is present in the circulation in both the fasting and postprandial states, when it is bound 
to albumin. Immediately following consumption of a meal rich in retinol and retinyl esters (~1 mg/kg 
body weight), mean plasma concentration of retinoic acid increased to 254 nmol/L but was quickly 
restored to fasting concentrations of 14 nmol/L in 10 male volunteers (Arnhold et al., 1996).  
Plasma/serum concentrations of retinyl- and retinoyl-β-glucuronides have been reported to be in the 
range of 5–15 nmol/L (Barua and Olson, 1986; Barua et al., 1989). Although it has been proposed that 
retinyl- and retinoyl-β-glucuronides, which are known to be readily hydrolysed by a number of β-
glucuronidases, may serve as sources of retinoids for tissues, it is generally believed that these fully 
water-soluble metabolites are filtered in the kidney and eliminated quickly from the body. 
Average fasting blood concentrations of β-carotene in the range 0.2–0.7 μmol/L have been reported in 
adult European populations (Al-Delaimy et al., 2004; Hercberg et al., 2004). A dose–response 
relationship between carotenoid intake and appearance in plasma has been shown (Rock et al., 1992). 
Individuals consuming 30 mg/day of supplemental β-carotene for five years had a mean fasting β-
carotene concentration of 3.75 µmol/L (Redlich et al., 1999).  
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2.3.3. Distribution to tissues 
The delivery of retinoids to tissues involves many different forms and carriers (Paik et al., 2004; 
O'Byrne and Blaner, 2013). Quantitatively the two most important pathways are those involving 
retinol bound to RBP4 and the postprandial delivery pathway. 
When needed, hepatic retinyl esters are hydrolysed to free retinol, which is mobilised from the liver 
bound to its plasma transport protein, RBP4. Retinol–RBP4 is secreted from the liver into the 
circulation as a means of delivering retinol to peripheral tissues (Goodman et al., 1965; Soprano and 
Blaner, 1994; Quadro et al., 1999; Packer, 2005). Liver is the major site of synthesis of RBP4, but 
other tissues, including adipose tissue, kidney, lung, heart, skeletal muscle, spleen, eyes and testes, 
also express RBP4, which may be important for recycling retinoids from peripheral tissues back to the 
liver (Blomhoff et al., 1991). Studies on intestinal cells indicate that retinol enters by diffusion, and 
this is probably true for other cell types (During et al., 2002; During and Harrison, 2004; During et al., 
2005; During and Harrison, 2007), although part of the uptake of RBP-bound retinol into specific 
target tissues is mediated by a cell surface receptor for RBP4 termed STRA6 (stimulated by retinoic 
acid 6). STRA6 is expressed on the surface of cells of several organs such as Sertoli cells, yolk sac and 
chorioallantoic placenta, choroid plexuses and retinal pigmented epithelial cells (Bouillet et al., 1997; 
Lewis et al., 2002; Blaner, 2007; Kawaguchi et al., 2007; Pasutto et al., 2007; Berry et al., 2013). 
In the postprandial delivery pathway, retinyl esters in chylomicrons in the circulation are taken up by 
tissues as the chylomicron undergoes lipolysis and remodelling. Approximately 66–75 % of 
chylomicron retinyl esters are cleared by the liver in the rat, with the remainder cleared by peripheral 
tissues (Goodman et al., 1965; Blaner et al., 1994; van Bennekum et al., 1999). Postprandial 
unesterified retinol taken up by cells is thought to bind immediately to CRBPs that are present in 
tissues (Noy and Blaner, 1991). Once retinol is formed upon retinyl ester hydrolysis within the 
hepatocyte, it is quickly bound by apo-CRBPI, which is in molar excess of retinol in these cells 
(Harrison et al., 1987). 
In humans, the two major sites of conversion of provitamin A carotenoids to retinoids appear to be the 
intestine (Section 2.3.1) and the liver (Harrison, 2012). Provitamin A carotenoids in VLDL and LDL 
are presumably taken up along with the lipoprotein particles by their cell surface receptors. Many 
tissues, including the liver, intestine, kidney, skin, skeletal muscle, adrenal gland, pancreas, testis, 
ovary, prostate, endometrium, mammary tissue, eyes and the mammalian embryo, express the enzyme 
BCMO1 and are all capable of converting β-carotene to retinoids (Yan et al., 2001; Lindqvist and 
Andersson, 2002; Chichili et al., 2005; Lindqvist et al., 2005). The maximum capacity for β-carotene 
cleavage by the intestine and the liver combined was estimated to be 12 mg β-carotene/day in a human 
adult (During et al., 2001). The liver and the intestine were both shown to have substantial β-carotene 
15,15-oxidoreductase activity (During et al., 2001). A study using a compartmental modelling 
approach showed that both the intestine and the liver should be considered to fit the prediction of the 
model to the experimental data for in vivo β-carotene conversion to retinol (Novotny et al., 1995). A 
study using stable isotope-labelled β-carotene (dose of 6 mg) showed that, on average, in a well-
nourished population, 81 % of total vitamin A formed from a β-carotene dose is from intestinal 
cleavage and 19 % is from extra-intestinal cleavage (post-absorptive or whole body) (Tang et al., 
2003).  
Plasma retinoic acid may also be taken up into tissues through a “flip-flop” mechanism across 
phospholipid bilayers (Noy, 1992b, 1992a) and contribute to tissue pools (Kurlandsky et al., 1995).  
2.3.4. Storage 
The main storage form of retinol is retinyl esters. The liver and intestine are the major tissue sites of 
retinol esterification, but other tissues, including the eye, lung, adipose tissue, testes, skin and spleen, 
are also able to esterify retinol and accumulate retinyl ester stores. The enzyme responsible for most 
retinyl ester formation is LRAT. Liver LRAT is thought to be structurally identical to intestinal LRAT 
(Section 2.3.1.1), although hepatic but not intestinal LRAT expression appears to be regulated by the 
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vitamin A nutritional status (Matsuura and Ross, 1993). The concentration of retinoic acid in tissues is 
generally very low, usually 100 to 1 000 times less than that of retinol and retinyl esters. 
2.3.4.1. Liver stores 
It is considered that in healthy individuals with an adequate vitamin A status, 70–90 % of retinol of the 
body is stored in the liver and that this percentage decreases to 50 % or below in severely deficient 
individuals (Rietz et al., 1973; Bausch and Rietz, 1977; Olson, 1987). Based on empirical data, Rietz 
et al. (1973) indicated that, in rats with an adequate vitamin A intake, 80 % of the retinol content of 
the body is stored in the liver. There is a lack of direct measurement in humans. Using stable isotope 
and model-based compartmental analysis to study retinol kinetics in one healthy human volunteer in 
the USA, von Reinersdorff et al. (1998) predicted that 80 % of the absorbed dose of labelled retinol 
was contained in the liver seven days after administration.  
The major part of retinoids is concentrated in the lipid droplets of hepatic stellate cells (Hendriks et al., 
1985; Moriwaki et al., 1988; Blomhoff et al., 1991; Blaner et al., 2009), where nearly all of the 
retinoids present is stored as retinyl ester (primarily retinyl palmitate, with smaller amounts of retinyl 
stearate, retinyl oleate and retinyl linoleate) (Blaner et al., 1985; Blomhoff et al., 1991; Blaner et al., 
2009). Unesterified retinol accounts for less than 1 %. 
Hepatocytes are responsible for the uptake of chylomicron remnant retinoids into the liver, which are 
then transferred to hepatic stellate cells (Blaner et al., 1985; Blomhoff et al., 1991). Hepatocytes 
account for about 10–20 % of the retinoids stored in the liver (Blaner et al., 1985; Blaner et al., 2009). 
Hepatocytes are the sole hepatic cellular site of RBP4 synthesis and possess enzymatic activities 
needed for the hydrolysis of retinyl esters and the synthesis and catabolism of retinoic acid (Blaner et 
al., 1985; Blaner et al., 2009).  
2.3.4.2. Adipose tissue stores 
Adipocytes are able to accumulate significant retinyl ester stores (O'Byrne and Blaner, 2013). Data in 
rats indicate that the adipose tissue may account for as much as 15–20 % of the total body retinoids 
(Tsutsumi et al., 1992). Data in humans are lacking. As in the liver, retinyl esters stored in adipose 
tissue can be mobilised and secreted back into the circulation bound to RBP4 synthesised in 
adipocytes (Tsutsumi et al., 1992; Zovich et al., 1992; Wei et al., 1997). These retinyl esters are first 
hydrolysed by hormone-sensitive lipase, which acts as retinyl ester hydrolase in adipocytes (Wei et al., 
1997; Strom et al., 2009). 
2.3.4.3. Efficiency of storage 
The efficiency of storage represents the fraction of ingested retinol which is absorbed and retained in 
the body (and more particularly in the liver).  
Upon i.v. administration of 
3
H-labelled retinol to rats with different vitamin A stores, the percentage of 
storage in the liver was shown to be relatively constant, between 50 and 63 %, in the range of liver 
retinol concentrations of 18–54 µg/g (Bausch and Rietz, 1977). The percentage of 3H-labelled retinol 
stored in the liver decreased (6–40 %) when initial hepatic stores of retinol were below 18 µg/g liver 
(0.06 µmol/g) (Bausch and Rietz, 1977).  
Using a radio-isotopic method, whole-body retinol retention was assessed in groups of Indian children 
(2–10 years) by measuring radioactivity in urine and faeces over four to six days after administration 
of a labelled dose (Reddy and Sivakumar, 1972; Sivakumar and Reddy, 1972). When the labelled dose 
of retinyl acetate was administered with 1 000 µg unlabelled retinyl acetate, mean retention was 82.2 ± 
2.0 % in healthy children (n = 5) and 57.6 ± 6.0 % in a group of children (n = 8) with infection. When 
the labelled dose of retinyl palmitate was administered with a high dose of 60 000 µg retinyl palmitate 
in five healthy children, 47 % of the dose was retained, on average. Using similar methodology, 
retention in the range of 48–54 % was estimated in healthy Indian children (n = 17; 3–6 years), when 
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labelled retinyl acetate was administered with a high dose of 60 000 µg unlabelled retinyl acetate 
(Kusin et al., 1974). The liver retinol content of these children is unknown. 
The efficiency of storage in the liver was measured by stable isotopic methods in 31 adult Bangladeshi 
surgery patients. Liver biopsy samples were taken 9–11 days after the administration of an oral dose of 
labelled retinol (215 µg/kg body weight (0.753 µmol/kg body weight) as retinyl acetate) (Haskell et 
al., 1997). In patients with hepatic concentrations greater than or equal to 20 µg retinol/g of liver 
(0.07 µmol/g) (mean ± SD estimated hepatic stores 40 ± 18 mg RE (139 ± 64 µmol RE)), average 
efficiency of storage in the liver was 42 % (± 13 %). The efficiency of storage in the liver was 
significantly lower (30 ± 8 %) in subjects with a concentration < 20 µg retinol/g of liver (mean ± SD 
estimated hepatic stores 14 ± 4 mg RE (50 ± 16 µmol RE). The Panel notes the low hepatic retinol 
stores of the study population and the short timeframe of the study, which may not have allowed the 
retinol dose to fully equilibrate with the hepatic pool (see Section 2.4.1.2).  
The Panel notes that available data show that the efficiency of storage depends on vitamin A status. 
Low retinol stores are associated with a reduced efficiency of storage. Data from adult Bangladeshi 
subjects with liver concentrations ≥ 20 µg retinol/g indicate an average efficiency of storage of 
ingested retinol of 42 % in the liver. The Panel notes that this would correspond to an efficiency of 
storage in the whole body of 52 %, assuming that 80 % of retinol body stores are found in the liver in 
subjects with adequate liver stores.  
2.3.5. Metabolism 
Retinoic acid is produced from retinol in two oxidative steps. Retinol is first oxidised to retinal, which 
is further oxidised to retinoic acid.  
Two types of enzymes have been implicated in the oxidation of retinol to retinal: the microsomal 
dehydrogenases of the short-chain dehydrogenases/reductases family of proteins and the cytosolic 
alcohol dehydrogenases of the medium-chain alcohol dehydrogenases family (Pares et al., 2008). The 
latter appear to rather play a role as backup enzymes under extreme dietary conditions (Farjo et al., 
2011; Napoli, 2012).  
The oxidation of retinal to retinoic acid is irreversible. Excessive retinoic acid is catabolised by several 
cytochrome P450 (CYP) enzymes, giving rise to more water-soluble oxidised and conjugated retinoid 
forms, which can be more easily excreted (White et al., 1996; Fujii et al., 1997; Ray et al., 1997; 
White et al., 1997). CYP26A1, CYP26B1 and CYP26C1 appear to be primarily responsible for the 
degradation of retinoic acid (Pennimpede et al., 2010; Ross and Zolfaghari, 2011; Kedishvili, 2013). 
With the exception of liver, where CYP26A1 is the predominant form, and lung, where CYP26A1 is 
slightly more abundant, all other human adult tissues contain higher levels of CYP26B1 transcript (Xi 
and Yang, 2008; Topletz et al., 2012). Considering that CYP26A1 expression in the liver is very 
sensitive to retinoic acid levels, the high catalytic efficiency of this low-affinity enzyme would enable 
CYP26A1 to rapidly bring down excessive levels of retinoic acid. In addition to the three CYP26 
enzymes, several other members of other CYP families have been shown to catabolise retinoic acid 
(Kedishvili, 2013).  
Retinal can be converted back to retinol (Kedishvili, 2013), depending on the availability of the 
substrates and cofactors. The cytosolic aldo-keto reductases and the microsomal short-chain 
dehydrogenases/reductases have been proposed to catalyse the reduction of retinal back to retinol. This 
efficient recycling of retinal back to retinol prevents retinal losses through the irreversible pathway to 
retinoic acid and constitutes a sparing process of retinol stores. 
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2.3.6. Elimination 
2.3.6.1. Catabolic losses 
The absolute catabolic rate (µg/day or µmol/day) and the fractional catabolic rate (% of a defined 
pool) of retinol are defined as the rate at which retinol is irreversibly utilised each day in absolute or 
relative amounts, respectively. 
The distribution and catabolism of retinol was determined in eight men who received intravenous or 
oral doses of 
14
C‐labelled retinyl acetate during vitamin A depletion (up to 771 days) and repletion (up 
to 372 days) (Sauberlich et al., 1974). It took about 26 days for the labelled dose to equilibrate with the 
total body vitamin pool, which was estimated to range from 315 to 879 mg (1 100–3 070 µmol). A 
fractional catabolic rate of the total body retinol pool of approximately 0.5 % per day (range 0.3–
0.9 %) was determined in these subjects consuming a vitamin A-free diet, deduced from a mean half-
life of retinol in the liver of 154 days (range 75–241 days, CV 35 %) during the depletion phase 
(Sauberlich et al., 1974; Olson, 1987). The absolute utilisation rate of retinol ranged between 1 113 
and 2 070 µg (3.9 and 7.2 µmol) per day among subjects at baseline and fell to low levels as depletion 
progressed (50–180 µg (0.2–0.6 µmol) per day). 
The total body retinol content determined by the plasma isotopic ratios of deuterium-labelled retinol 
was significantly different between groups of four US and Bangladeshi adults (mean ± SD (range) 
295 ± 13 mg (106–378 mg) (1 030 ± 45 µmol (370–1 320 µmol)) vs. 286 ± 315 mg (86–745 mg) 
(100 ± 110 µmol (30–260 µmol)), p = 0.003) (Haskell et al., 1998). Based on the disappearance 
kinetics of the fraction of labelled dose in plasma at equilibrium derived from the data of Haskell et al. 
(1998), Furr et al. (2005) estimated the mean fractional catabolic rate of retinol to be 0.4 % per day 
(range 0.1–0.7 % per day) in the US subjects and 0.9 % per day (range 0.5–1.2 % per day) in the 
Bangladeshi subjects. The difference was not statistically significant. It also did not differ from the 
rate of 0.5 % per day previously determined (Sauberlich et al., 1974).  
Based on the same approach, Haskell et al. (2003) estimated a fractional catabolic rate of 2.2 % per 
day (95 % CI = 1.4–3.0 % per day) in 107 Peruvian children (12–24 months of age) with a total body 
retinol content (mean ± SD (range)) estimated as 28 ± 23 mg (4–112 mg) (97 ± 81 µmol (16–
392 µmol)). According to the authors, the higher fractional catabolic rate in children aged 12–
24 months may reflect greater utilisation of the vitamin to support growth, but other factors may have 
affected the retinol turnover, given that plasma C-reactive protein concentrations were elevated in 
approximately 50 % of the children. The authors suggested that healthy children (12–24 months of 
age) may have a fractional catabolic rate lower than 2.2 %.  
Applications of model-based compartmental analysis to data from tracer label studies have allowed 
estimation of parameters of human retinol metabolism, including its catabolic rate (von Reinersdorff et 
al., 1998; Furr et al., 2005; Cifelli et al., 2008). Such analyses also revealed the important recycling of 
vitamin A among tissues and plasma before its irreversible utilisation, indicating a sparing process of 
the vitamin (Reinersdorff et al., 1996; Furr et al., 2005; Cifelli et al., 2008).  
Cifelli et al. (2008) investigated retinol kinetics, storage, and catabolic rate through model-based 
compartmental analysis of data from stable isotope dilution in well-nourished men and women from 
China (Wang et al., 2004) and the USA (Tang et al., 2003). [
2
H8]-Retinyl acetate (3 mg (8.9 µmol)) 
was orally administered to US (n = 12; 59 ± 9 years) and Chinese adults (n = 14; 54 ± 4 years) and 
serum tracer and retinol concentrations were measured from 3 hours to 56 days. Subjects were 
instructed not to consume vitamin supplements or foods containing large amounts of retinol or β-
carotene during the study. Serum retinol concentration was significantly higher in the US group 
(487 ± 92 µg/L (1.70 ± 0.32 µmol/L)) than in the Chinese group (355 ± 106 µg/L 
(1.24 ± 0.37 µmol/L), p < 0.001) at baseline. Predicted total traced mass (257 ± 182 vs. 68 ± 32 mg 
(898 ± 637 vs. 237 ± 109 µmol)), absolute catabolic rate (“disposal rate”) (4.2 ± 1.7 vs. 
1.6 ± 0.6 mg/day (14.7 ± 5.87 vs. 5.58 ± 2.04 µmol/day)) and system residence time (58.8 ± 28.5 vs. 
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42.9 ± 14.6 days) were significantly greater in US than in Chinese subjects. In both the US and 
Chinese participants, absolute retinol catabolic rate was significantly correlated with the traced mass in 
the extravascular compartment (256 ± 182 and 67 ± 32 mg (892 ± 637 and 233 ± 109 µmol), 
respectively), with the catabolic rate increasing linearly with increasing stores. The Panel notes that 
estimated mean daily fractional catabolic rates of 1.6 % (14.7/898) in the US subjects and 2.3 % 
(5.58/237) in the Chinese subjects would result from the predicted total traced mass and absolute 
catabolic rate in these two groups, with large inter-individual variability. The Panel notes that the 
absorption efficiency of retinol (i.e. the portion in compartment 1 that is transferred to compartment 2) 
estimated by the model is around 65 % in the US subjects. This is likely to underestimate the true 
absorption, as retinol administered in oil is considered to be almost completely absorbed (Sivakumar 
and Reddy, 1972) (Section 2.3.1.1). This would lead to an underestimation of the predicted total body 
pool. Therefore, the fractional catabolic rates derived from these data are likely to overestimate actual 
fractional catabolic rates.  
The Panel notes that the rate of retinol catabolism is related to body stores and that the absolute 
catabolic rate appears to increase with vitamin A body stores. Overall, retinol catabolism represents a 
relatively low fraction of the total body pool, owing to the important storage capacity of the body and 
efficient recycling processes. The Panel notes that available studies were conducted in subjects with a 
wide range of retinol body stores using different experimental methods and conditions and show 
substantial variability. The results of the study by Cifelli et al. (2008) indicate that the fractional 
catabolic rate may be higher than the value of 0.5 % which has usually been considered (Olson, 1987). 
The Panel notes that the fractional catabolic rate may be influenced by physiological conditions (such 
as growth, presence of inflammation or other non-identified factors) and that the fractional catabolic 
rate may be higher in children than in adults, in relation to a higher retinol utilisation for growth needs 
and, possibly, to relatively lower body stores than in adults.  
2.3.6.2. Faecal, breath and urinary losses 
The majority of retinol metabolites are excreted in the urine, but they are also excreted in faeces and 
breath. The percentage of a radioactive dose of 
14
C‐labelled retinyl acetate recovered in breath, faeces 
and urine ranged from 18 to 30 %, from 18 to 37 % and from 38 to 60 %, respectively, after 400 days 
on a vitamin A-deficient diet (Sauberlich et al., 1974). Retinol is metabolised in the liver to numerous 
products, some of which are conjugated with glucuronic acid or taurine for excretion in bile (Zile et 
al., 1982; Skare and DeLuca, 1983), and the amount of retinol metabolites excreted in bile increases as 
the liver retinol exceeds a critical concentration. Excretion of labelled retinol metabolites in bile of rats 
fed increasing amounts of retinol traced by [
3
H]-retinyl acetate was constant when hepatic retinol 
concentrations were low (≤ 32 µg/g (112 nmol/g) and increased rapidly (by eight-fold) as liver retinol 
concentration increased, up to a plateau at hepatic retinol concentration ≥ 140 µg/g (490 nmol/g) 
(Hicks et al., 1984). This increased biliary excretion may serve as a protective mechanism for reducing 
the risk of excess storage of vitamin A.  
2.3.6.3. Breast milk 
Preformed vitamin A in breast milk primarily occurs as retinyl esters (mainly retinyl palmitate) 
(Stoltzfus and Underwood, 1995), with a small fraction present as free retinol. Provitamin A 
carotenoids are also found in breast milk (Canfield et al., 2003). The carotenoid concentration of 
breast milk is not described in this opinion, as carotenoids are not taken into account in estimating the 
vitamin A supply in infants, owing to a lack of knowledge on the bioconversion of carotenoids in 
infants (SCF, 2003; EFSA NDA Panel, 2014b), and secretion of provitamin A carotenoids in breast 
milk is unlikely to significantly affect the vitamin A status of lactating women.  
Preformed vitamin A concentration is higher in colostrum and decreases as lactation progresses 
(Stoltzfus and Underwood, 1995). It is not related to breast milk fat concentration during the first 
weeks of lactation (Macias and Schweigert, 2001) but is influenced by maternal vitamin A status 
(Underwood, 1994b).  
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Appendix C reports data on retinol
7
 concentration in breast milk from mothers of term infants in 
Western populations. In a multinational study, Canfield et al. (2003) found mean retinol 
concentrations between 301 and 352 µg/L in samples of mature milk from Western populations 
(Australia, Canada, the UK and the USA). Studies on samples taken during the first six months of 
lactation reported average retinol concentrations in mature milk of 831 µg/L in Germany (Schweigert 
et al., 2004), 815 µg/L in Turkey (Tokusoglu et al., 2008) and 571 µg/L in Poland (Duda et al., 2009). 
In a group of Polish lactating women, Kasparova et al. (2012) found decreasing concentrations of 
retinol in mature breast milk over the course of lactation, from 458 µg/L at 1–2 months post partum to 
229 µg/L at 5–6 months post partum and 172 µg/L at 9–12 months post partum.  
During the first six months of lactation, the Panel notes that available data indicate that mean total 
retinol concentrations in mature breast milk of populations from Western countries range between 229 
and 831 µg/L. Average values between 450 and 600 µg/L have previously been considered by other 
committees (DH, 1991; SCF, 1993; Afssa, 2001; IOM, 2001; WHO/FAO, 2004; D-A-CH, 2013; 
Nordic Council of Ministers, 2014). Based on a mean milk transfer of 0.8 L/day (Butte et al., 2002; 
FAO/WHO/UNU, 2004; EFSA NDA Panel, 2009) and a concentration of retinol in breast milk of 
530 µg/L taken as the midpoint of the range of means (229–831 µg/L), a secretion of 424 µg/day of 
retinol in breast milk is estimated during the first six months of lactation.  
2.3.7. Interaction with other nutrients 
Serum retinol concentration was positively associated with serum iron and ferritin concentrations in 
children (Bloem et al., 1989). Vitamin A deficiency impairs iron mobilisation and vitamin A 
supplementation improves haemoglobin concentrations (Lynch, 1997). Iron supplementation 
combined with vitamin A was more effective than iron alone in improving haemoglobin 
concentrations in anaemic children (Mwanri et al., 2000) and pregnant and lactating women (Suharno 
et al., 1993; Tanumihardjo et al., 1996; Tanumihardjo, 2002). In a systematic review, vitamin A 
supplementation during pregnancy was found to reduce anaemia risk (haemoglobin < 11.0 g/dL) 
among both anaemic and non-anaemic women (Thorne-Lyman and Fawzi, 2012). This is consistent 
with observational and intervention studies in women and children which showed correlations between 
anaemia and vitamin A deficiency and the amelioration of anaemia by improving vitamin A status in 
deficient populations (Radhika et al., 2002; Semba and Bloem, 2002; Al-Mekhlafi et al., 2013). In 
non-anaemic subjects, a test meal containing 1 000 µg retinol did not enhance iron absorption 
(Walczyk et al., 2003). Iron deficiency was shown to alter the distribution of retinol and retinyl esters 
between plasma and liver and to reduce plasma retinol concentrations in rats, despite adequate 
vitamin A intake and hepatic retinol stores (Amine et al., 1970; Staab et al., 1984; Rosales et al., 
1999). 
Zinc is important in protein synthesis. In animal models, zinc deficiency affects RBPs and transport of 
retinol from the liver to the circulation (Terhune and Sandstead, 1972; Smith et al., 1974; Duncan and 
Hurley, 1978; Baly et al., 1984). In addition, zinc deficiency also reduced the synthesis of rhodopsin in 
rats (Dorea and Olson, 1986). However, no consistent relationship between zinc and vitamin A status 
has been established in humans (Christian and West, 1998). 
2.3.8. Retinol equivalents 
In tissues, blood, milk and food, vitamin A contents are conventionally expressed as RE, with 1 μg RE 
equal to 1 μg retinol.  
The vitamin A activity of provitamin A carotenoids in diets is determined from specific relations 
between provitamin A carotenoids and retinol to account for the less efficient absorption of 
carotenoids and their bioconversion to retinol. Conversion factors of 1:6 for β-carotene and 1:12 for 
other provitamin A carotenoids were initially proposed (FAO/WHO, 1988; SCF, 1993), based on data 
indicating that 3 µg of dietary β-carotene is equivalent to 1 µg of purified β-carotene in oil and that the 
                                                     
7 That is, after saponification to release retinol from retinyl esters. 
Dietary Reference Values for vitamin A 
 
EFSA Journal 2015;13(3):4028 21 
β-carotene:retinol equivalency ratio of purified β-carotene in oil is approximately 2:1 (Sauberlich et 
al., 1974). β-Carotene is the most potent retinol precursor of all provitamin A carotenoids (Harrison, 
2012). Stoichiometric conversion of 1 mole of β-carotene (with two β-ionone rings) would give rise to 
2 moles of retinol (via retinal), whereas conversion of 1 mole of either β-cryptoxanthin or α-carotene 
(each with only a single β-ionone ring) would give rise to a single mole of retinol. α-Carotene and β-
cryptoxanthin show 30–50 % of the provitamin A activity of β-carotene (Bauernfeind, 1972; van Vliet 
et al., 1996). 
In 2001, the Institute of Medicine (IOM) revised these factors considering new data (IOM, 2001): (1) 
absorption of β-carotene from a mixed vegetable diet had been reported to be 14 % compared with 
absorption of β-carotene in oil (van het Hof et al., 1999); (2) absorption from green leafy vegetables 
appeared to be lower than absorption from fruits (de Pee et al., 1998); and (3) a low proportion of β-
carotene was consumed from fruits compared with vegetables in the USA. Retinol activity 
equivalency
8
 ratios of 1:12 for β-carotene and 1:24 for other provitamin A carotenoids were proposed. 
Considering the data from van het Hof et al. (1999), WHO/FAO (2004) also proposed revised 
equivalency factors of 1:14 for β-carotene and 1:28 for other provitamin A carotenoids from usual 
vegetable diets, with possible adjustment depending on the proportion of green leafy vegetables or 
fruits in the diet. West et al. (2002) suggested that these revised conversion factors might still be too 
high, especially for populations living in developing countries. Two recent reviews (Haskell, 2012; 
Van Loo-Bouwman et al., 2014) provide an overview of experimental data on β-carotene:retinol 
equivalency ratios published until early 2011 and mid-2013, respectively. 
Reviews of data on the bioavailability of β-carotene from plant sources in humans (Haskell, 2012; Van 
Loo-Bouwman et al., 2014) reported absorption ranging from 5 to 65 % and retinol equivalency ratios 
for β-carotene ranging from 3.8:1 to 28:1 by weight. In line with de Pee et al. (1998), there was further 
indication that β-carotene from fruits is better converted than β-carotene from green leafy vegetables 
(Khan et al., 2007). For pure β-carotene diluted in oil, equivalency ratios from 2:1 to 55:1 were 
reported, with most values being between 2:1 and 4:1. The data collected by Haskell (2012) indicate 
that the efficiency of conversion of β-carotene from oil might be increased in subjects with “low or 
marginal” vitamin A status compared with subjects with “adequate” vitamin A status, while it appears 
to decrease with increasing dose of β-carotene. Overall, there is high variability in retinol equivalency 
ratios, which might originate from either host-related factors (genetics, age, sex, nutritional status, 
digestive dysfunctions and illness) or food-related factors (food composition, food matrix) (de Pee and 
Bloem, 2007; Tanumihardjo et al., 2010; Haskell, 2012). A study in eight healthy free-living adults 
who received an oral tracer dose of [
14
C]-β-carotene also confirms that β-carotene conversion is highly 
variable (Ho et al., 2009). 
Few results are available on the rate of absorption of β-carotene and its bioequivalence to retinol in 
children (Van Loo-Bouwman et al., 2014). By measuring the plasma ratio of retinol formed from 
labelled β-carotene compared with a reference dose of labelled retinol, van Lieshout et al. (2001) 
estimated that the amount of β-carotene in oil required to form 1 μg retinol was 2.4 μg (95 % CI = 2.1–
2.7 μg) in 36 Indonesian children aged 8–11 years. In a study in 68 Chinese children (6–8 years) using 
labelled retinyl acetate as a reference, the mean (± SE) conversion factors of pure β-carotene, β-
carotene from Golden Rice and β-carotene from spinach to retinol were 2.0 ± 0.9, 2.3 ± 0.8 and 
7.5 ± 0.8 to 1, respectively (Tang et al., 2012). Ribaya-Mercado et al. showed a significant 
improvement in vitamin A status, as assessed by the deuterated retinol dilution method, in Filipino 
schoolchildren receiving controlled diets rich in provitamin A carotenoids from fruit and vegetable 
sources, but these studies do not allow the estimation of provitamin A carotenoid/retinol equivalency 
ratios (Ribaya-Mercado et al., 2000; Ribaya-Mercado et al., 2007).  
                                                     
8 Retinol Activity Equivalents (RAEs) were defined by IOM (2001) assuming that, after absorption of -carotene, whether 
from oil or from food, the metabolism of the molecule is similar and that the retinol equivalency ratio of -carotene in oil 
is 2:1. To take into account the lower absorption efficiency of -carotene from food compared with that from oil, the 
vitamin A activity of -carotene from food can be derived by multiplying by 2:1. For example, it was estimated that 6 µg 
of -carotene from a mixed diet is nutritionally equivalent to 1 µg of -carotene in oil. Therefore, the retinol activity 
equivalency (µg RAE) ratio for -carotene from food was estimated to be 12:1 (6 × 2:1). 
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The Panel notes the high variability in the β-carotene/retinol equivalency ratios estimated from these 
studies, depending on the food matrix, the subjects’ vitamin A status and the dose administered. This 
results in large uncertainties in establishing equivalency ratios from the whole diet of large 
populations. The Panel considers that current evidence is insufficient to support a change from the 
conversion factors proposed by the SCF for European populations, namely 1 μg RE equals 1 μg of 
retinol, 6 μg of β-carotene and 12 μg of other carotenoids with provitamin A activity.  
2.4. Biomarkers 
2.4.1. Total body retinol content and liver retinol concentration  
Vitamin A status can best be expressed in terms of total body pool of retinol (i.e. as free retinol and 
retinyl esters) or, alternatively, in terms of liver concentration of the vitamin (Olson, 1987). Hepatic 
concentration is considered as a marker of vitamin A status because 70–90 % of the retinol in the body 
is stored in the liver in healthy individuals, while this percentage is considered to decrease to 50 % or 
below in severely deficient individuals (Rietz et al., 1974; Bausch and Rietz, 1977; Olson, 1987) 
(Section 2.3.4.1). 
Olson (1987) has proposed a minimum concentration of 20 µg retinol/g liver (0.07 µmol/g) (i.e. as free 
retinol and retinyl esters) as a criterion to define adequate vitamin A status, based on the following 
considerations: (1) no clinical signs of deficiency have been noted in individuals with this or a higher 
liver concentration; (2) at this concentration and above, the liver is capable of maintaining a steady-
state plasma retinol concentration, as determined by the relative dose–response test in rats (Loerch et 
al., 1979) and humans (Amedee-Manesme et al., 1987); (3) biliary excretion of retinol increases 
significantly when liver stores rise significantly above this concentration in rats (Hicks et al., 1984), 
which is suggested to serve as a regulatory mechanism of vitamin A storage; and (4) this concentration 
was calculated to be sufficient to protect an adult ingesting a diet free of vitamin A from a deficiency 
state for approximately four months as well as to meet vitamin A needs during shorter periods of stress 
(e.g. infection).  
This value has commonly been used as a reference point to define adequate vitamin A status in the 
scientific literature (Olson, 1987), as well as to derive vitamin A requirements (SCF, 1993; IOM, 
2001; WHO/FAO, 2004). The Panel considers that a concentration of ≥ 20 µg retinol/g liver 
(0.07 µmol/g) can be considered to reflect an adequate vitamin A status. 
2.4.1.1. Direct measurement 
Liver retinol concentrations have been directly determined by post-mortem liver analysis and analysis 
of biopsy samples. Post-mortem liver analysis indicated concentrations of retinol ranging from 10 to 
1 807 µg/g liver (0.03 to 6.3 µmol/g) in Western countries (Hoppner et al., 1969; Underwood et al., 
1970; Raica et al., 1972; Mitchell et al., 1973; Money, 1978; Huque, 1982; Schindler et al., 1988). 
Mean and median retinol concentrations were 252 µg/g (0.9 µmol/g) and 198 µg/g (0.7 µmol/g) (range 
0–1 201 µg/g (0–4.2 µmol/g) in post-mortem analysis of the liver of 364 British males and females 
(aged 0 to > 90 years) (Huque, 1982). Mean (± SD) and median retinol concentrations of 
597 ± 397 µg/g (2.1 ± 1.4 µmol/g) and 506 µg/g (1.8 µmol/g) (range 36–1 807 µg/g (0.1–6.3 µmol/g)) 
were found in post-mortem analysis of the liver of 77 men and women (mean age 56 years) in 
Germany (Schindler et al., 1988). Analysis of liver biopsy samples performed in low-income countries 
showed hepatic concentrations of 17–141 µg/g (0.1–0.5 µmol/g) (Suthutvoravoot and Olson, 1974; 
Abedin et al., 1976; Olson, 1979; Flores and de Araujo, 1984; Furr et al., 1989; Haskell et al., 1997). 
However, post-mortem liver analysis and liver biopsies are not feasible in population-based studies as 
primary status indicators for obvious reasons. 
2.4.1.2. Indirect measurement by stable isotope dilution methods 
Total body content and liver retinol concentration can be estimated indirectly by stable isotope dilution 
approaches (Haskell et al., 2005; IAEA, 2008). After oral administration of a small dose of retinol 
tracer labelled with stable deuterium (
2
H) or carbon (
13
C), the dilution of tracer in plasma is measured 
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when the labelled dose has mixed with endogenous stores and equilibrium is reached (14–20 days 
after administration). Total body exchangeable retinol pool can be derived from a mass balance 
equation, correcting for the efficiency of absorption and storage of retinol and its fractional catabolic 
rate (Furr et al., 1989; Furr et al., 2005; IAEA, 2008).  
In the deuterated retinol dilution (DRD) technique, the retinol pool is calculated from an equation 
developed by Furr et al. (1989),
9
 considering efficiency of absorption and storage of retinol, its 
catabolic rate and inequality of the plasma to liver ratio of labelled to non-labelled retinol. The 
absorption and storage efficiency factor is usually assumed to be 50 % based on data from Bausch and 
Rietz (1977) (see Section 2.3.4.3). To adjust for the catabolism of the labelled dose during the 
equilibration period, a fractional catabolic rate of 0.5 % is typically considered, derived from the half-
life of retinol turnover in adults (Sauberlich et al., 1974) (see Section 2.3.6.1). To account for the fact 
that unlabelled retinol is continuously consumed in the diet and newly absorbed retinol contributes 
preferentially to the plasma pool, another factor is applied to correct for the difference in specific 
activity in liver compared with plasma. A value of 0.65 is usually assumed, derived from the ratio 
observed in rats (Hicks et al., 1984). This factor is not needed if no retinol, or as little as possible, is 
consumed during the equilibration period. 
In the [
13
C2]-retinol isotope dilution ([
13
C2]-RID) test, the dose of tracer administered is smaller than in 
the DRD technique, which reduces the degree to which the dose perturbs the endogenous retinol pool 
(Furr et al., 2005). For this test, a dose absorption of 90–100 % is assumed and there is no correction 
for the differences in distribution of the tracer between liver and serum (Valentine, 2013).  
For both techniques, hepatic stores can be further determined by considering that the amount of retinol 
stored in the liver is positively correlated with the size of the total body pool. Between 40 and 90 % of 
the total body retinol pool is assumed to be stored in the liver, depending on the vitamin A status of 
the subjects (Rietz et al., 1974; Bausch and Rietz, 1977) (Section 2.3.4.1). 
Based on data from 10 adult subjects in the USA, the correlation coefficient between liver retinol 
concentrations calculated from the DRD method (range 19–321 µg/g liver (0.065–1.12 µmol/g)) and 
directly measured in liver biopsies (range 14–160 µg/g liver (0.049–0.56 µmol/g)) was 0.88, and the 
Spearman’s rank correlation coefficient was 0.95 (p < 0.002) (Furr et al., 1989). Based on data from 
31 Bangladeshi surgery patients, Haskell et al. (1997) found good agreement between mean hepatic 
stores of retinol estimated by the DRD technique (32 ± 21 mg (0.110 ± 0.072 mmol)) and by liver 
biopsy (29 ± 19 mg (0.100 ± 0.067 mmol)), assuming that liver weight is 2.4 % of body weight. A 
significant linear relationship was found between the two techniques (r = 0.75, p < 0.0001). However, 
a wide prediction interval was observed for estimates of hepatic retinol stores for individual subjects.  
Liver and total body retinol stores assessed by stable isotope dilution methods have been shown to be 
well correlated with measures of habitual vitamin A intake in cross-sectional studies over a wide range 
of intakes (Pearson correlation coefficients around 0.4) (Ribaya-Mercado et al., 2004; Valentine et al., 
2013) and to respond to vitamin A supplementation in intervention studies lasting a couple of weeks 
(Haskell et al., 1999; Ribaya-Mercado et al., 1999; Haskell et al., 2011).  
                                                     
9 Total body exchangeable vitamin A pool = F × dose × [S × a × ((1/D:H) – 1)], where:  
 F is a factor related to the efficiency of absorption and storage of the orally administered dose;  
 dose is the amount of isotope orally administered (mmol);  
 the factor S corrects for the inequality of the plasma to liver ratio of labelled to non-labelled retinol; this correction 
is not needed if subjects consume as little vitamin A as possible after administering the oral dose, while the isotope 
is mixing with exchangeable vitamin A pools;  
 the factor a corrects for irreversible loss of labelled vitamin A during the equilibration period;  
 D:H is the isotopic ratio of labelled to non-labelled retinol in plasma; 
 and –1 corrects for the contribution of the dose to the total body vitamin A reserve (this term is omitted when the 
mass of the labelled vitamin A is small compared with the mass of total body vitamin A). 
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The Panel notes that there are uncertainties inherent in stable isotope dilution methods owing to the 
assumptions required in the calculations. Human data on the parameters used are limited, so that inter-
individual variability and the influence of factors such as age are not well characterised (IAEA, 2008). 
The methods also assume that the fractional catabolic rate is independent of the size of the stores of 
retinol, which is unlikely, as indicated by data in rats (Green and Green, 1994) and humans 
(Sauberlich et al., 1974; Cifelli et al., 2008) (Section 2.3.6.1). Despite these limitations, they have the 
advantage that they enable a quantitative estimation of retinol stores. The Panel notes that these 
methods provide good estimates at group level, but lack precision for their determination at individual 
level, owing to the large inter-individual variability of the factors used in the equation. 
2.4.1.3. Relative dose–response 
The relative dose–response (RDR) is an indirect measurement of hepatic retinol stores. In conditions 
of vitamin A deficiency, RBP that is not bound to retinol (apo-RBP) accumulates in the liver, but is 
rapidly released from the liver into the circulation after administration of a dose of retinol or retinyl 
esters (Muto et al., 1972; Smith et al., 1973; Loerch et al., 1979). 
In this test, after an oral dose of retinol, the relative excess of apo-RBP in the liver binds to retinol and 
the resulting holo-RBP (RBP bound with retinol), coupled with transthyretin, is released into the 
circulation. Two blood samples are collected, at baseline and five hours after dosing, and the RDR 
value is calculated as follows:  
RDR (in %) = [(serum retinol concentration at five hours post-dosing – serum retinol 
concentration at baseline)/serum retinol concentration at five hours post-dosing] × 100.  
Alternative methods have been proposed, e.g. by measuring serum RBP instead of serum retinol 
concentration (Fujita et al., 2009), or by administrating the 3,4-didehydroretinyl ester analogue instead 
of retinol as the test dose (modified RDR) (Tanumihardjo, 1993).  
The RDR test is considered a valid test to determine inadequate vitamin A status. A large positive 
response to the dose, i.e. an RDR value > 20 %, is indicative of vitamin A deficiency, whereas a value 
< 20 % is considered to reflect hepatic concentrations equivalent to or above 20 µg retinol/g 
(0.07 µmol/g) (Tanumihardjo, 1993; WHO, 1996; Tanumihardjo, 2011). However, the synthesis of 
RBP also depends on the adequacy of energy intake and of other nutrients such as zinc and protein. In 
addition, plasma retinol concentration and, consequently, the RDR test are insensitive across a wide 
range of liver concentrations above 20 µg retinol/g (0.07 µmol/g) (Solomons et al., 1990). 
The Panel considers that the RDR represents a good marker of inadequate vitamin A status, but its 
sensitivity is limited to liver concentrations below 20 µg retinol/g (0.07 µmol/g). 
2.4.2. Plasma/serum retinol concentration 
In the usual range, plasma/serum retinol concentration is neither related to observed habitual vitamin 
A intake from either dietary preformed vitamin A or provitamin A carotenoid sources nor responsive 
to supplement use (IOM, 2001; Tanumihardjo, 2011).  
The concentration of plasma/serum retinol is under tight homeostatic control (Olson, 1984). The 
relationships between plasma/serum retinol and total body retinol content or liver retinol concentration 
are not linear. Plasma/serum retinol concentrations reflect liver retinol stores only when they are 
severely depleted (< 20 µg retinol/g liver (< 0.07 µmol/g)) or very high (> 300 µg/g liver 
(1.05 µmol/g)) (WHO, 2011). A plasma/serum retinol concentration below 200 µg/L (0.7 µmol/L) is 
considered to reflect vitamin A inadequacy for population assessment (Sommer, 1982; Olson, 1987; 
Flores, 1993; Underwood, 1994a; WHO, 2011). The prevalence of values below 200 µg/L 
(0.7 µmol/L) is a generally accepted population cut-off for preschool-age children to indicate risk of 
inadequate vitamin A status (WHO, 1996, 2011), whilst values above 300 µg/L (1.05 µmol/L) indicate 
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an adequate status related to the absence of clinical signs of deficiency (Pilch, 1987; Flores et al., 
1991).  
A low plasma/serum retinol concentration may also originate from an inadequate supply of dietary 
protein, energy, or zinc, which are required for synthesis of RBP, or may be caused by infection and 
inflammation resulting in decreases in the concentrations of some acute phase proteins, such as RBP 
and transthyretin (IOM, 2001; Tanumihardjo, 2011). Infection can lower mean plasma/serum retinol 
concentration by as much as 25 %, independently of vitamin A intake (Filteau et al., 1993; Christian et 
al., 1998b).  
The Panel notes that the specificity of plasma/serum retinol concentration is affected by a number of 
factors unrelated to vitamin A status, including infection and inflammation, which make the 
interpretation of this biomarker difficult. In addition, plasma/serum retinol concentrations are 
maintained nearly constant over a wide range of vitamin A intakes.  
2.4.3. Markers of visual function 
Xerophthalmia is the most specific vitamin A deficiency disorder (Section 2.2.2.1). It encompasses the 
clinical spectrum of ocular manifestations of vitamin A deficiency, from milder stages of night 
blindness and Bitot’s spots, to potentially blinding stages of corneal xerosis, ulceration and necrosis 
(WHO, 2009). The prevalence of xerophthalmia is considered a population indicator of vitamin A 
deficiency (WHO, 2009; Tanumihardjo, 2011). 
2.4.3.1. Night blindness 
The rhodopsin molecule of the rods in the retina contains 11-cis retinal (Section 2.2.1). Without an 
adequate supply of vitamin A to the retina, the function of the rods in dim light situations is affected, 
resulting in abnormal dark adaptation, i.e. night blindness (Carney and Russell, 1980).  
Numerous tests have been used to assess the presence of night blindness (WHO, 2012). The most 
common method used at population level involves subjective reports on current or past night blindness 
status. Objective measures have also been developed based on dark adaptation or the scoptic response 
to various light stimuli after dark adaptation. They include dark adaptometry, the pupillary response 
test and the night vision threshold test.  
Measures of night blindness and dark adaptometry are sensitive markers of vitamin A status at the 
lower end of the status continuum (liver concentration < 20 µg retinol/g (0.07 µmol/g)) 
(Tanumihardjo, 2011). Epidemiological evidence suggests that host resistance to infection is impaired 
prior to clinical onset of night blindness and laboratory animals fed a vitamin A-deficient diet maintain 
ocular concentrations of vitamin A despite a significant reduction in liver retinol concentration (IOM, 
2001).  
In addition, zinc deficiency and severe protein deficiency also may affect dark adaptation responses 
(Morrison et al., 1978; Bankson et al., 1989). 
2.4.3.2. Conjunctival impression cytology 
Vitamin A deficiency leads to early keratinising metaplasia (Bitot’s spots) and losses of mucin-
secreting goblet cells on the bulbar surface of the conjunctiva of the eye (IOM, 2001). Cells can be 
counted and evaluated by microscopic examination of a filter paper impression from the surface of the 
eye and staining with haematoxylin and eosin (Tanumihardjo, 2011). However, there have been 
concerns about the performance of this method to assess vitamin A deficiency when compared with 
biochemical markers (e.g. serum retinol or RDR) (Amedee-Manesme et al., 1988; Gadomski et al., 
1989; Rahman et al., 1995; Sommer and West, 1996). This technique was used in the 1990s, but, 
because of its limitations, has not been widely adopted (Tanumihardjo, 2011).  
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2.4.3.3. Conclusion on markers of visual function 
The Panel notes that markers of visual function have been used for population evaluation of vitamin A 
status or to assess intervention efficacy. However, these methods are rather qualitative and their 
sensitivity is limited to situations of vitamin A deficiency (Tanumihardjo, 2011). 
2.4.4. Conclusion on biomarkers 
The Panel notes that plasma/serum retinol concentration is under tight homeostatic control and does 
not reflect vitamin A status until body stores are very low (or very high). In contrast, measures of total 
body content or liver concentration by stable isotope dilution methods have shown good correlation 
with habitual vitamin A intake, over a wide range of intakes.  
As reviewed by Tanumihardjo (2011), the sensitivity of markers of visual function is limited to 
situations of vitamin A deficiency. Likewise, the RDR is a useful marker of inadequate status only. In 
contrast, stable isotope dilution methods give a quantitative estimate of liver retinol concentrations 
over a broad range, from vitamin A deficiency to toxicity. 
The Panel considers that measurements of the total body retinol content or liver retinol concentration 
are the most specific and sensitive markers of vitamin A status. Liver concentration < 20 µg retinol/g 
(0.07 µmol/g) (i.e. as free retinol and retinyl esters) can be used as an indicator of vitamin A 
deficiency, while concentrations above this value are considered to maintain adequate plasma retinol 
concentrations, prevent clinical signs of deficiency and reflect adequate vitamin A status.  
2.5. Effects of genotypes 
In recent years, large subsets of molecular components of the metabolism of retinoids have been 
identified (D'Ambrosio et al., 2011). Mutations in the corresponding genes can cause various diseases, 
including retinitis pigmentosa and Stargardt disease, that lead to severe vision impairment and often 
blindness (Palczewski, 2010). Moreover, mutations in these genes can cause Matthew–Wood 
syndrome, a fatal disease which is associated with anophthalmia, pulmonary and cardiac malfunctions 
and severe mental retardation (Blaner, 2007). 
Many proteins participate in the processes involved in the intestinal metabolism of retinol and 
carotenoids. Given the important role of these proteins in the absorption of dietary carotenoids, their 
conversion to retinol, and the incorporation of both carotenoids and retinyl esters into chylomicrons, it 
is not surprising that polymorphisms in these genes affect carotenoid transport and metabolism 
(Erlanson and Borgstrom, 1968; von Lintig, 2010). Single nucleotide polymorphisms in SR-B1 (Borel 
et al., 2007) and in BCMO1 (Ferrucci et al., 2009; Leung et al., 2009) have been associated with 
alterations in the metabolism of carotenoids and retinoids in humans. In humans, a heterozygotic 
mutation in BCMO1 was described with evidence of both elevated plasma β-carotene concentration 
and low plasma retinol concentration (Lindqvist et al., 2007).  
Mutations in the retinal pigment epithelium-specific 65 kDa protein (RPE65) in humans result in 
chromophore deficiency and blindness (Marlhens et al., 1997). 
The Panel considers that genotype probably induces inter-individual differences in vitamin A 
requirement but present knowledge is limited and cannot be used for setting DRVs for vitamin A. 
3. Dietary sources and intake data 
3.1. Dietary sources 
Foods rich in retinol include offal and meat, butter, retinol-enriched margarine, dairy products and 
eggs, while foods rich in provitamin A carotenoids, in particular β-carotene, include vegetables and 
fruits, such as sweet potatoes, carrots, pumpkins, dark green leafy vegetables, sweet red peppers, 
mangoes and melons (FSA, 2002; Anses/CIQUAL, 2012).  
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Currently, vitamin A (as retinol, retinyl acetate, retinyl palmitate and β-carotene) may be added to 
foods
10
 and food supplements.
11
 The vitamin A content of infant and follow-on formulae
12
 and of 
processed cereal-based foods and baby foods for infants and young children
13
 is regulated.  
3.2. Dietary intake 
EFSA estimated dietary intake of vitamin A from food consumption data from the EFSA 
Comprehensive Food Consumption Database (EFSA, 2011b), classified according to the food 
classification and description system FoodEx2 (EFSA, 2011a). Data from 12 dietary surveys in nine 
EU countries were used. The countries included were Finland, France, Germany, Ireland, Italy, Latvia, 
the Netherlands, Sweden and the UK. The data covered all age groups from children to adults 
(Appendix D). 
Nutrient composition data for vitamin A were derived from the EFSA Nutrient Composition Database 
(Roe et al., 2013). The vitamin A content of foods, expressed as RE, was calculated by considering 
that 1 μg RE equals 1 μg retinol and 6 μg β-carotene. Other provitamin A carotenoids (i.e. α-carotene 
and β-cryptoxanthin) were not taken into account because of the limited availability of data concerning 
these compounds in the database. 
Food composition information from Finland, Germany, Italy, the Netherlands and the UK was used to 
calculate vitamin A intake in these countries, assuming that the best intake estimate would be obtained 
when both the consumption data and the composition data are from the same country. For vitamin A 
intake estimates of Ireland and Latvia, food composition data from the UK and Germany, respectively, 
were used, because no specific composition data from these countries were available. EFSA intake 
estimates are based on consumption of foods, either fortified or not (i.e. without dietary supplements). 
Average vitamin A intake ranged between 409 and 651 μg RE/day in children aged 1 to < 3 years, 
between 607 and 889 μg RE/day in children aged 3 to < 10 years, between 597 and 1 078 μg RE/day 
in children aged 10 to < 18 years, and between 816 and 1 498 μg RE/day in adults. Average daily 
intakes were in most cases slightly higher in males (Appendix E) than in females (Appendix F), 
mainly owing to the larger quantities of food consumed per day. 
Among children aged 1 to < 3 years, food products for the young population, vegetables and vegetable 
products, milk and dairy products contributed significantly to vitamin A intake. In the older age 
groups, in addition to the vegetable and vegetable products and milk and dairy products, meat and 
meat products and animal and vegetable fats also contributed to vitamin A intake (Appendices G and 
H). Differences in the main contributors to vitamin A intake between sexes were minor.  
When available, EFSA vitamin A intake estimates were compared with published intake estimates 
from the same national surveys. EFSA intake estimates were found to differ by 1–10 % from the 
published results of the EsKiMo and VELS surveys in Germany (Kersting and Clausen, 2003; 
Mensink et al., 2007), the National Diet and Nutrition Survey in the UK (Bates et al., 2012) and the 
National Adult Nutrition Survey in Ireland (IUNA, 2011). Differences were found to be higher, up to 
24 %, compared with published results from the INCA 2 survey in France (Afssa, 2009) and the third 
INRAN-SCAI survey in Italy (Sette et al., 2011). Comparisons were not possible for Finland (Helldán 
et al., 2013), Sweden (Amcoff et al., 2012) and the Netherlands (van Rossum et al., 2011) owing to the 
use of different conversion factors for provitamin A carotenoids for calculating vitamin A content of 
foods. Uncertainties in the estimates may be caused by differences in disaggregating data for 
                                                     
10 Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of 
vitamins and minerals and of certain other substances to foods. OJ L 404, 30.12.2006, p. 26.  
11  Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of 
the Member States relating to food supplements. OJ L 183, 12.7.2002, p. 51.  
12 Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending 
Directive 1999/21/EC. OJ L 401, 30.12.2006, p. 1.  
13 Commission Directive 2006/125/EC of 5 December 2006 on processed cereal-based foods and baby foods for infants and 
young children. OJ L 339, 06.12.2006, p. 16–35. 
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composite dishes before intake estimations; inaccuracies in mapping food consumption data according 
to the FoodEx2 classification; analytical errors or errors in estimating vitamin A content of foods in 
the food composition tables; the use of borrowed vitamin A values from other countries; or the 
replacement of missing vitamin A contents for some foods by values for similar foods or food groups 
in the vitamin A intake estimation process. It is not possible to conclude which of these intake 
estimates would be closer to the actual vitamin A intake. 
4. Overview of Dietary Reference Values and recommendations  
4.1. Adults 
In their revision of the Nordic Nutrition Recommendations (NNR), the Nordic countries decided to 
maintain their earlier recommendations of 900 µg RE/day for men and 700 µg RE/day for women 
(Nordic Council of Ministers, 2014), which was based on the approach adopted by IOM (2001). A 
study in men using the DRD technique to estimate vitamin A requirement was noted (Haskell et al., 
2011), but it was considered that more studies on the variation in the AR were needed before a change 
in the current recommendations could be proposed.  
D-A-CH (2013) derived an AR for men of 600 µg RE/day, which was reported to have been 
determined experimentally. Using a CV of 30 %, a recommended intake of 1 000 µg RE/day for men 
was proposed. The recommended intake for women was set at 800 µg RE/day, i.e. 20 % less than that 
for men, considering that their average plasma concentration is lower (Heseker et al., 1994).  
At the FAO/WHO Expert consultation of 1998 (WHO/FAO, 2004), experts maintained the approach 
that had been proposed previously (FAO/WHO, 1988). The mean requirement
14
 was defined as the 
minimum daily intake of vitamin A required to prevent xerophthalmia in the absence of clinical or 
subclinical infection. A mean requirement of 4–5 µg/kg body weight per day was estimated from the 
depletion–repletion study by Sauberlich et al. (1974). Vitamin A mean requirements of 300 µg RE/day 
for men and 270 µg RE/day for women were proposed. The “safe level of intake” was defined as the 
average continuing intake of vitamin A required to permit vitamin A-dependent functions and to 
maintain an acceptable total body store of the vitamin. This store helps to offset periods of low intake 
or increased need resulting from infection and other forms of stress. Recommended Safe Intakes of 
500 µg RE/day for women aged 19–65 years, 600 µg RE/day for women aged > 65 years and 
600 µg RE/day for men were set. These were calculated by estimating the average dietary intake of 
retinol needed to replace the endogenous stores that are lost,
15
 following the approach proposed by 
Olson (1987), and considering a CV of 20 %. The CV was estimated from data on the half-life of 
vitamin A reported by Sauberlich et al. (1974). Equivalency factors of 1:14 for β-carotene and 1:28 for 
other provitamin A carotenoids from usual vegetable diets were recommended (van het Hof et al., 
1999), which may be adjusted depending on the proportion of green leafy vegetables or fruits in the 
diet.  
IOM (2001) estimated the requirement for vitamin A based on the assurance of adequate stores of 
vitamin A. A minimum acceptable liver vitamin A concentration of 20 µg/g (0.07 µmol/g) was 
considered. At this concentration, no clinical signs of deficiency are observed, adequate plasma retinol 
concentrations are maintained (Loerch et al., 1979), induced biliary excretion of vitamin A is observed 
(Hicks et al., 1984) and protection against vitamin A deficiency is ensured for approximately four 
months while consuming a vitamin A-deficient diet. The Estimated Average Requirement (EAR) was 
calculated by multiplying the percentage of body vitamin A stores lost per day when ingesting a 
vitamin A-free diet (0.5 %), the minimum acceptable liver retinol concentration (20 µg/g), the liver 
weight:body weight ratio (1:33), the reference weight for a specific age group and sex (61 and 76 kg 
for women and men, respectively), the ratio of total body:liver vitamin A stores (10:9) and the 
efficiency of storage of ingested vitamin A (40 %) (Olson, 1987). This resulted in an EAR of 627 µg 
Retinol Activity Equivalent (RAE)/day for men and 503 µg RAE/day for women. A CV of 20 % was 
                                                     
14 Previously defined as “basal requirement” by FAO/WHO (1988). 
15 Previously defined as “mean normative storage requirement” by FAO/WHO (1988). 
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used to derive the Recommended Dietary Allowance (RDA) based on the estimated half-life of 
vitamin A. RDAs of 900 µg RAE/day for men and 700 µg RAE/day for women were set. The IOM 
revised conversion factors of carotenoids and retinol to account for data suggesting a lower absorption 
of provitamin A carotenoids (de Pee et al., 1998; Parker et al., 1999; van het Hof et al., 1999). Retinol 
activity equivalency factors of 12:1 for dietary β-carotene and 24:1 for other dietary provitamin A 
carotenoids were proposed (Section 2.3.8).  
Afssa (2001) considered a vitamin A requirement of 600 µg RE/day, based on data from the 
depletion–repletion study by Hume and Krebs (1949) and the radioisotope study by Sauberlich et al. 
(1974). Given the small number of subjects involved in these studies, an individual variation of 30 % 
was considered and a PRI of 800 µg RE/day for men was proposed. For women, the value was 
extrapolated from the value for men on the basis of energy requirements and set at 600 µg RE/day. 
Afssa recommended 350 µg RE/day to be provided by β-carotene (2.1 mg/day). The vitamin A 
activity of carotenoids in the diet was expressed in RE based on conversion factors of 6:1 for dietary 
vitamin A:β-carotene and 12:1 for vitamin A:other dietary provitamin A carotenoids. Because older 
adults may be at particular risk for hypervitaminosis A due to protein deficiency or renal failure, Afssa 
proposed to set the PRI at 700 µg RE/day for men and 600 µg RE/day for women over 75 years 
(Ward, 1996). 
The SCF (1993) considered the approach proposed by Olson (1987), using a liver concentration of 
20 µg retinol/g (0.07 µmol/g) as a criterion for vitamin A sufficiency. The mean dietary intake needed 
to maintain this concentration was calculated assuming that the liver store represents 90 % of the total 
body vitamin A pool and the efficiency of storage in the liver is 50 %. Based on studies with 
radioactive vitamin A, a mean fractional catabolic rate of 0.5 % was considered. This results in a mean 
daily dietary intake of 6.7 µg RE/kg body weight, corresponding to an AR of 500 µg RE/day for men 
and 400 µg RE/day for women. A CV of 20 % was considered from the rates of depletion observed 
experimentally. The PRI was set at 700 µg RE/day for men and 600 µg RE/day for women. 
Conversion factors of 6:1 for dietary vitamin A:β-carotene and 12:1 for vitamin A:other dietary 
provitamin A carotenoids were recommended.  
The Netherlands Food and Nutrition Council (1992) identified a minimum requirement of vitamin A 
for adults of 600 µg RE/day, which was observed to be sufficient to prevent deficiency symptoms such 
as electroretinographic anomalies and changes in the eyes and the skin, and to maintain plasma retinol 
concentration at a minimum of 0.7 µmol/L (Sauberlich et al., 1974). An Adequate intake (AI) of 
1 000 µg RE/day for men and 800 µg RE/day for women was proposed.  
The UK Committee on Medical Aspects of Food Policy (COMA) (DH, 1991) referred to the approach 
proposed by FAO/WHO (1988), which based recommendations on the maintenance of an adequate 
body pool size, considering the concentration of vitamin A in the liver. The PRIs were set at 
700 µg RE/day for men and 600 µg RE/day for women.  
Table 1:  Overview of Dietary Reference Values for vitamin A for adults 
 
NCM 
(2014) 
D-A-CH 
(2013) 
WHO/FAO 
(2004) 
Afssa 
(2001) 
IOM 
(2001) 
SCF 
(1993)
 
NL 
(1992) 
DH 
(1991) 
Age (years)  ≥ 19 ≥ 19 19–65 ≥ 19 ≥ 19 All ≥ 19 Adults 
PRI Men (µg RE/day) 900 1 000 600 
(a)
 800 900 
(b)
 700 1 000 
(c)
 700 
PRI Women (µg RE/day) 700 800 500 
(a)
 600 700 
(b)
 600 800 
(c)
 600 
Age (years)    > 65 ≥ 75     
PRI Men (µg RE/day)   600 
(a)
 700     
PRI Women (µg RE/day)   600 
(a)
 600     
NCM, Nordic Council of Ministers; NL, Netherlands Foods and Nutrition Council; PRI, Population Reference Intake; RE, 
Retinol Equivalent; RAE, Retinol Activity Equivalent. 
(a):  Recommended Safe Intake. 
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(b):  Expressed in µg RAE/day. 
(c):  Adequate Intake. 
4.2. Infants and children 
The Nordic countries maintained their earlier approach and extrapolated recommended intakes for 
children and adolescents from those for adults by using metabolic body weight (body weight to the 
power of 0.75) and growth factors (Nordic Council of Ministers, 2014). 
From observed intakes of breast-fed infants in developing countries with no signs of deficiency and 
normal growth, WHO/FAO (2004) estimated a requirement of 180 µg RE/day for infants aged 0–6 
months and increased it to 190 µg RE/day for infants aged 7–12 months. Considering vitamin A 
intakes from breast milk in well-nourished communities, a Recommended Safe Intake of 
375 µg RE/day was proposed in early infancy (1.75 µmol/L × 0.75 L/day) and increased to 
400 µg RE/day for infants aged 7–12 months, taking into consideration that vitamin A-deficient 
populations are at increased risk of death from six months onwards. The requirement and 
Recommended Safe Intake for preschool children were derived from the values set in late infancy (i.e. 
20 and 39 µg RE/kg body weight per day) and estimated to be in the range of 200–400 µg RE/day. 
Such values were supported by intakes observed to relieve signs of deficiency and reduce the risk of 
mortality in Indian children (Rahmathullah et al., 1990) and maintain serum retinol concentrations of 
0.7 µmol/L in American preschool children (Ballew et al., 2001). Recommendations for older children 
were derived from adult values. 
IOM (2001) proposed an AI of 500 µg RAE/day for infants aged 7–12 months, considering that the 
extrapolation from the AI set for infants aged 0–6 months fed breast milk resulted in an estimate of 
483 µg RAE/day, and that the estimation of total intakes based on the calculated intake from human 
milk (485 µg/L × 0.6 L/day = 291 µg/day) and observed intake from complementary foods 
(244 µg/day, n = 44, Third National Health and Nutrition Examination Survey) resulted in an estimate 
of 535 µg RAE/day. For children and adolescents, no data were available to estimate an average 
requirement. EARs were extrapolated from adults using metabolic weight (body weight to the power 
of 0.75), which provided higher values than using isometric scaling (linear with body weight). This 
was to ensure a sufficient RDA, based on indications from studies conducted in developing countries 
that xerophthalmia and serum retinol concentrations of less than 200 µg/L exist among preschool 
children with daily vitamin A intakes of up to 200 µg, whereas 300 µg/day of vitamin A is associated 
with serum retinol concentrations greater than 300 µg/L (Reddy, 1985). The RDA was set by using a 
CV of 20 %, as for adults. 
For infants, Afssa considered an intake of 350 µg RE/day, based on a breast milk concentration of 
500 µg RE/L and an ingested volume of 750 mL/day. For children, Afssa (2001) extrapolated the data 
from adults based on energy requirements. 
The SCF (1993) proposed a PRI of 350 µg RE/day for infants aged 6–11 months based on the amount 
of vitamin A ingested with breast milk (FAO/WHO, 1988). PRIs for older children were set to make a 
smooth transition from infant to adult values. Although it was considered that there is little evidence to 
support these values, they appeared unlikely to be underestimates. A daily intake of about 300 µg has 
been reported to meet requirements of preschool children (Reddy, 1985).  
For infants aged 6–11 months, the Netherlands Food and Nutrition Council (1992) set an AI on the 
basis of the concentration of vitamin A in breast milk. For children and adolescents, AIs were 
calculated by interpolation from the values for infants and adults, and an allowance was made for body 
weight and growth. 
For infants, the UK COMA (DH, 1991) adopted the approach proposed by FAO/WHO (1988), which 
is described above. Values for children were interpolated from the values for infants and adults. 
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Table 2:  Overview of Dietary Reference Values for vitamin A for infants and children 
 NCM 
(2014) 
D-A-CH 
(2013) 
WHO/FAO 
(2004) 
Afssa 
(2001) 
IOM 
(2001)
 
SCF 
(1993) 
NL 
(1992) 
DH 
(1991) 
Age (months) 6–11 4–12 7–12 0–12 7–12 6–11 6–11 7–12 
PRI (µg RE/day)  300 600 400 
(a)
 350 500 
(b)
 350 400 
(c)
 350 
Age (years) 1–2 1–4 1–3 1–3 1–3 1–3 1–4 1–3 
PRI (µg RE/day)  300 600 400 
(a)
 400 300 
(b)
 400 400 
(c)
 400 
Age (years) 2–5 4–7 4–6 4–6 4–8 4–6 4–7 4–6 
PRI (µg RE/day)  350 700 450 
(a)
 450 400 
(b)
 400 500 
(c)
 400 
Age (years) 6–9 7–10 7–9 7–9 9–13 7–10 7–10 7–10 
PRI (µg RE/day)  400 800 500 
(a)
 500 600 
(b)
 500 700 
(c)
 500 
Age (years) 10–13 10–13 10–18 10–12 14–18 11–14 10–13 11–14 
PRI Boys (µg RE/day) 600 900 600 
(a)
 550 900 
(b)
 600 1 000 
(c)
 600 
PRI Girls (µg RE/day) 600 900 600 
(a)
 550 700 
(b)
 600   800 
(c)
 600 
Age (years) 14–17 13–15  13–15  15–17 13–16 15–18 
PRI Boys (µg RE/day) 700 1 100  700  700 1 000 
(c)
 700 
PRI Girls (µg RE/day) 700 1 000  600  600 800 
(c)
 600 
Age (years)  15–19  16–19   16–19  
PRI Boys (µg RE/day)  1 100  800   1 000 
(c)
  
PRI Girls (µg RE/day)  900  600   800 
(c)
  
NCM, Nordic Council of Ministers; NL, Netherlands Foods and Nutrition Council; PRI, Population Reference Intake; RE, 
Retinol Equivalent; RAE, Retinol Activity Equivalent. 
(a): Recommended Safe Intake. 
(b): Expressed in µg RAE/day. 
(c): Adequate Intake. 
4.3. Pregnancy  
The Nordic countries considered a retinol accumulation of 50 µg/day in the fetus and set a 
recommended intake of 800 µg RE/day for pregnant women to cover individual variation (Nordic 
Council of Ministers, 2014). 
D-A-CH (2013) estimated that pregnant women should ingest on average one-third more than non-
pregnant women, and a recommended intake of 1 100 µg RE/day was proposed throughout pregnancy. 
WHO/FAO (2004) considered that a newborn infant appears to require around 100 µg retinol/day to 
meet its needs for normal growth and assumed that the fetus has similar needs during the third 
trimester of pregnancy. Recognising that a large portion of the world’s population of pregnant women 
live under conditions of deprivation, an increment of 200 µg RE/day was proposed during the whole 
period of pregnancy, in order to enhance maternal storage during early pregnancy and to cover the 
needs of the rapidly growing fetus in late pregnancy. Finally, the Recommended Safe Intake was 
increased by 300 µg RE/day compared to that of non-pregnant women aged 19–65 years. 
The IOM used a model based on the accumulation of vitamin A in the liver of the fetus during 
gestation and assuming that the liver contains approximately half of the body’s amount of vitamin A 
when liver stores are low, as is the case for newborns (IOM, 2001). A concentration of 3 600 µg per 
fetus was calculated. Assuming the efficiency of maternal vitamin A absorption to average 70 % and 
vitamin A to be accumulated mostly in the last 90 days of pregnancy, the maternal requirement would 
be increased by around 50 µg/day during the last trimester. As vitamin A in the maternal diet may be 
stored and mobilised later as needed and some vitamin A may be retained in the placenta, the IOM 
proposed an additional requirement of 50 µg RAE/day for the entire pregnancy. The RDA was set by 
using a CV of 20 %, as for non-pregnant adults. 
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Afssa (2001) noted that fetal requirements are low and low amounts of vitamin A are accumulated in 
fetal liver. An increase of the recommended intake to 700 µg RE/day during the last trimester of 
pregnancy was proposed.  
The SCF (1993) proposed a PRI of 700 µg RE/day during pregnancy, in order to enhance maternal 
storage to provide adequate vitamin A for the growing fetus in late pregnancy. 
The Netherlands Food and Nutrition Council (1992) proposed an additional intake of 200 µg RE/day 
during pregnancy, based on fetal needs during the last three months of pregnancy (Olson and Hodges, 
1987). 
The UK COMA considered that an increment of 100 µg RE/day during pregnancy should enhance 
maternal storage and allow adequate vitamin A for the growing fetus in late pregnancy (DH, 1991). 
Table 3:  Overview of Dietary Reference Values for vitamin A for pregnant women 
 NCM 
(2014) 
D-A-CH 
(2013) 
WHO/FAO 
(2004) 
Afssa 
(2001) 
IOM 
(2001)
 
SCF 
(1993)
 
NL 
(1992) 
DH 
(1991) 
Age (years)     14–18    
PRI (µg RE/day)  800 1 100 800 
(a)
 700 
(b)
 750 
(c)
 700 1 000 
(d)
 700 
Age (years)     ≥ 19    
PRI (µg RE/day)       770 
(c)
    
NCM, Nordic Council of Ministers; NL, Netherlands Foods and Nutrition Council; PRI, Population Reference Intake; RE, 
Retinol Equivalent; RAE, Retinol Activity Equivalent. 
(a): Recommended Safe Intake. 
(b): Third trimester of pregnancy. 
(c): Expressed in µg RAE/day. 
(d):  Adequate Intake. 
4.4. Lactation 
The Nordic countries proposed an additional intake of 400 µg RE/day for lactating women, to 
compensate for the amount of vitamin A secreted in breast milk and considering reported values for 
breast milk vitamin A concentration of 450–600 µg RE/L in Western countries and an average milk 
production of 750 mL/day (Nordic Council of Ministers, 2014). 
D-A-CH (2013) noted that the intake of breast-fed infants is about 500 µg RE/day (Souci et al., 2000). 
With prolonged breastfeeding, the vitamin A concentration of breast milk decreases while the breast-
fed infant requires additional vitamin A for growth. Mainly for women breastfeeding longer than four 
months an allowance of 700 µg RE/day was recommended to satisfy the infant’s requirement and to 
avoid deficits in the mother. 
WHO/FAO proposed an increment of 350 µg RE/day to replace the amount secreted in breast milk 
(WHO/FAO, 2004). 
The IOM considered that a breast-fed infant ingests on average 400 µg RAE/day in the first six 
months of life, and this was proposed as the additional EAR during lactation to maintain adequate 
vitamin A body stores of the mother (IOM, 2001). The RDA was set by using a CV of 20 %. 
Afssa considered that breastfeeding women secrete around 350 µg RE/day (based on a concentration 
of 500 µg RE/L and a secreted amount of 750 mL/day) and this was proposed as the additional amount 
during lactation to be added to the PRI for non-lactating women (Afssa, 2001). 
The SCF assumed that 350 µg RE/day is supplied in breast milk and proposed an increment of this 
amount throughout lactation (SCF, 1993). 
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The Netherlands Food and Nutrition Council (1992) recommended an additional intake of 
450 µg RE/day during lactation, to offset the loss of vitamin A through breast milk, assuming an 
average concentration of 550 µg/L. 
The UK COMA proposed an increment of 350 µg RE/day during lactation to cover the amount of 
vitamin A secreted with breast milk (DH, 1991). 
Table 4:  Overview of Dietary Reference Values for vitamin A for lactating women 
 NCM 
(2014) 
D-A-CH 
(2013) 
WHO/FAO 
(2004) 
Afssa 
(2001) 
IOM 
(2001)
 
SCF 
(1993)
 
NL 
(1992) 
DH 
(1991) 
Age (years)     14–18    
PRI (µg RE/day)  1 100 1 500 850 
(a)
 950  1 200 
(b)
 950 1 250 
(c)
 950 
Age (years)     ≥ 19    
PRI (µg RE/day)       1 300 
(b)
    
NCM, Nordic Council of Ministers; NL, Netherlands Foods and Nutrition Council; PRI, Population Reference Intake; RE, 
Retinol Equivalent; RAE, Retinol Activity Equivalent. 
(a): Recommended Safe Intake 
(b): Expressed in µg RAE/day. 
(c): Adequate Intake 
5. Criteria (endpoints) on which to base Dietary Reference Values 
The average requirement of vitamin A is defined as the intake required to permit adequate growth and 
other vitamin A-dependent functions and to maintain an acceptable total body pool of the vitamin. 
5.1. Indicators of vitamin A requirement 
The requirement of vitamin A has been estimated by other expert bodies on the basis of the amount 
needed to correct deficiency symptoms such as impaired dark adaptation among vitamin A-depleted 
subjects (Netherlands Food and Nutrition Council, 1992; Afssa, 2001); to raise plasma retinol 
concentration into the normal range in depleted subjects (Netherlands Food and Nutrition Council, 
1992; Afssa, 2001); and to maintain a given body pool size of retinol in well-nourished subjects (SCF, 
1993; IOM, 2001; WHO/FAO, 2004; Nordic Council of Ministers, 2014). 
5.1.1. Symptoms of vitamin A deficiency  
Xerophthalmia is the most specific clinical consequence of vitamin A deficiency (Section 2.2.2.1). 
Markers of visual function have been developed to assess vitamin A status (Section 2.4.3). However, 
data relating such measurements to dietary vitamin A intake are scarce. In a depletion–repletion study 
in eight men in whom vitamin A deficiency was induced, daily supplementation with around 300 µg 
retinol (4–5 µg/kg body weight) corrected abnormalities in adaptation to dark and electroretinographic 
patterns (Sauberlich et al., 1974). This amount may be considered the minimal dietary requirement in 
adults to maintain normal visual function. However, it is recognised that the prevalence of ocular 
manifestations (i.e. xerophthalmia) often underestimates the magnitude of functional vitamin A 
deficiency. Therefore, such amount may not cover other vitamin A-dependent functions (Section 
2.2.1) and allow an adequate total body pool of the vitamin to be maintained. 
The Panel considers that these indicators cannot be used for deriving DRVs for vitamin A. 
5.1.2. Plasma/serum retinol concentration 
Plasma/serum retinol concentration lacks sensitivity and specificity as a marker of vitamin A status in 
the general healthy population, because of the tight homeostatic control of retinol concentration over 
the range of adequate liver retinol concentrations and the influence of a number of confounding factors 
(Section 2.4.2). 
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The Panel considers that this marker cannot be used for deriving DRVs for vitamin A. 
5.1.3. Maintenance of total body retinol content and liver retinol concentration 
Liver retinol concentration is a biomarker of vitamin A status. A concentration of 20 µg retinol/g liver 
(0.07 µmol/g) in adults represents a level assumed to maintain adequate plasma retinol concentrations, 
to prevent clinical signs of deficiency and to provide adequate stores (Section 2.4.1). Accordingly, the 
Panel considers that a concentration of 20 µg retinol/g liver (0.07 µmol/g) can be used as a target value 
for establishing the requirement for vitamin A in adults. In the absence of specific data for infants and 
children, the Panel considers that the same target value as for adults can be used in these age groups. 
The dietary intake of vitamin A required to maintain this liver concentration can be determined from a 
factorial approach (Olson, 1987). Data on the relationship between dietary intake of vitamin A and 
retinol liver (or total body) stores measured by stable isotope dilution methods may also be used 
(Haskell et al., 2005) (Section 2.4.1.2).  
5.1.3.1. Factorial approach  
The vitamin A intake required to maintain a concentration of 20 µg retinol/g liver (0.07 µmol/g) can 
be calculated on the basis of the factorial approach proposed by Olson (1987), which takes into 
account the ratio of total body/liver retinol stores, the fractional catabolic rate of retinol and the 
efficiency of storage of ingested retinol. 
To apply the factorial approach, a number of assumptions have to be made: 
 The body store of retinol appears to be an important determinant of the catabolic rate of retinol 
(Section 2.3.6.1). Limited data are available on the fractional catabolic rate in subjects with 
adequate retinol body stores. Recent data indicate that the fractional catabolic rate may be higher 
than the value of 0.5 % which has usually been considered. Taking a conservative approach, the 
Panel assumes a fractional catabolic rate of 0.7 % for adults using the highest value of the range 
measured in four US adults at steady state (Section 2.3.6.1).  
 In healthy individuals with an adequate vitamin A status, 70–90 % of body retinol is stored in the 
liver (Section 2.3.4.1). The Panel notes the paucity of data in humans. The Panel assumes a ratio 
of 80 % for all age groups. 
 Available data indicate that the average efficiency of storage of retinol in the liver of adult 
subjects with adequate hepatic stores (≥ 20 µg retinol/g liver) is 42 %. Assuming that liver stores 
represent 80 % of the whole body stores in this population group, this would correspond to a 
storage efficiency in the whole body of 52 % (Section 2.3.4.3). The Panel assumes an efficiency of 
storage of retinol in the whole body of 50 % for all age groups. 
 Based on available data which show that the liver/body weight ratio decreases with age (Haddad et 
al., 2001; Young et al., 2009), the Panel assumes average liver/body weight ratios of 4.0 % up to 
3 years, 3.5 % from 4 to 6 years, 2.8 % from 7 to 14 years and 2.4 % above 15 years of age and in 
adults.  
 The Panel considers that maintenance needs for vitamin A expressed with respect to body weight 
are the same for adults and children. A growth component has to be added for children to take into 
account higher vitamin A utilisation for growth needs (Section 2.3.6.1). Growth factors were 
calculated as the proportional increase in protein requirement for growth relative to the 
maintenance requirement at the different ages, as follows: 0.57 for infants aged 7–11 months, 0.25 
for boys and girls aged 1–3 years, 0.06 for boys and girls aged 4–6 years, 0.13 for boys and girls 
aged 7–10 years, 0.11 for boys and 0.08 for girls aged 11–14 years, and 0.08 for boys and 0.03 for 
girls aged 15–17 years (EFSA NDA Panel, 2014a). 
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The Panel notes that data on total body/liver retinol stores in humans are scarce, that available 
information on the fractional catabolic rate and efficiency of storage of retinol comes from studies 
involving a small number of subjects and that the influence of factors such as age is not well 
characterised. 
5.1.3.2. Data from stable isotope dilution methods  
Haskell et al. (2011) investigated the amount of daily vitamin A required to maintain liver stores in a 
selected population of Bangladeshi men expected to have a liver retinol concentration close to 20 µg/g 
(0.07 µmol/g). During a 60-day intervention period, 16 subjects (18–32 years, body weight 50 kg) 
consumed a controlled basal diet containing 100 µg RAE/day and were randomly assigned to receive 
one of eight different amounts of retinol (range 100–1 000 µg/day; n = 2 per group) in the form of 
retinyl palmitate dissolved in corn oil. The total body retinol pool sizes and liver retinol concentrations 
were quantitatively estimated by using the DRD method before and after the intervention. A “semi-
quantitative” estimate of the change in retinol pool size was also obtained by estimating the change in 
plasma isotopic ratios on day 3 after dosing, before and after the intervention. Mean (± SD) estimated 
total body retinol pool sizes were 17 ± 9 mg (59 ± 32 µmol) at baseline and 18 ± 10 mg 
(64 ± 34 µmol) after the intervention, and liver retinol concentrations were 13 ± 7 µg/g 
(0.047 ± 0.025 µmol/g) and 14 ± 8 µg/g (0.049 ± 0.027 µmol/g), respectively. There were significant 
linear relationships between daily supplemental retinol intake and the changes in total body retinol 
pool size as assessed quantitatively (r = 0.62, p = 0.010) or “semi-quantitatively” (r = 0.68, p = 0.004). 
From the respective regression lines, the authors estimated that a daily supplement of 400 µg retinol 
(95 % CI = undefined–640) with the quantitative approach, and of 254 µg/day (95 % CI = 156–336) 
with the “semi-quantitative” approach, would be required to maintain the retinol pool size of 17 mg 
(60 µmol) (13 ± 7 µg/g liver (0.047 ± 0.025 µmol/g liver)). Considering the background dietary intake, 
vitamin A intakes of 500 or 354 µg RAE/day were derived from the two methods. The Panel notes that 
the estimated liver retinol concentration in the study population was lower than the target of 20 µg/g 
liver (0.07 µmol/g liver). The authors indicate that no signs or symptoms of vitamin A deficiency were 
identified in the subjects, but the publication does not provide details on the physical examination 
undertaken, including eye/vision assessment.  
Ribaya-Mercado et al. (2004) investigated the relationship between dietary vitamin A intake and total 
body and liver retinol stores in a cross-sectional study in men (n = 31, body weight 53.3 ± 9.7 kg) and 
women (n = 31, body weight 45.9 ± 10.1 kg) aged 60–88 years in the rural Philippines. Total body 
pool was assessed using the DRD method and vitamin A intake was estimated by three non-
consecutive 24-hour dietary recalls. Mean (± SD) (range) estimated retinol pool size was 75 ± 41 mg 
(11–190 mg) (263 ± 144 µmol (38–664 µmol)) in men and 62 ± 39 mg (6–169 mg) (215 ± 137 µmol 
(20–590 µmol)) in women. Assuming that liver weight was 2.4 % of body weight in adults and that, in 
these marginally nourished individuals, 70 % of total body retinol was found in the liver, the authors 
estimated a mean (± SD) liver retinol concentration of 40 ± 17 (range 7–74) µg/g (0.139 ± 0.058 
(range 0.026–0.260) µmol/g) in men and 40 ± 27 (range 5–125) µg/g (0.140 ± 0.095 (range 0.019–
0.438) µmol/g) in women. The mean vitamin intake of the men and women with a liver concentration 
≥ 20 µg retinol/g (0.07 µmol/g) (n = 53) was 135 ± 86 µg RAE/day (n = 27) and 134 ± 104 µg 
RAE/day (n = 26), respectively. 
Valentine et al. (2013) assessed the relationship between vitamin A intake and total body retinol pool 
size in another cross-sectional study in 40 non-pregnant, non-lactating US women (22.4 ± 2.3 years, 
body weight 61.2 ± 7.2 kg). Body pool size and liver stores were estimated by using a [
13
C2]-RID test. 
Mean (± SD) estimated total body retinol pool size was 234 ± 154 mg (range 41–893 mg) 
(816.5 ± 537.4 µmol (range 141.5–3 116 µmol)). Eighty per cent of total body retinol was assumed to 
be found in the liver and the liver weight was assumed to represent 2.4 % of body weight. Estimated 
mean liver retinol concentration was 129 ± 89 µg/g (0.45 ± 0.31 µmol/g) and ranged from 26 µg/g 
(0.09 µmol/g) to 513 µg/g (1.79 µmol/g). Mean (± SD) vitamin A intake as assessed by food 
frequency questionnaire (FFQ) (including supplements) was 1 213 ± 778 µg RAE/day (range 378–
3 890 µg RAE/day) and was positively correlated with liver retinol concentration and total body 
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retinol pool size (Pearson correlation coefficients 0.41 and 0.40, p = 0.009 and p = 0.011, 
respectively). Vitamin A intake was also estimated by a three-day dietary record; mean (± SD) 
estimate was 1 180 ± 705 µg RAE/day (range 78–3 020 µg RAE/day) and no significant correlation 
was found with liver retinol concentration and total body retinol pool size. In a subset of women with 
a mean daily vitamin A intake (521 ± 119 µg RAE/day) similar to the EAR set by the IOM (2001) on 
the basis of the Olson equation and a target liver concentration of 20 µg retinol/g (0.07 µmol/g), the 
authors found an average liver retinol concentration of 86 ± 29 µg/g (0.30 ± 0.10 µmol/g).  
In a group of 32 young women (19–30 years) in the USA with a mean (± SD) vitamin A intake of 
1 148 ± 782 µg RAE (assessed by FFQ, including supplements), Valentine (2013) estimated a mean 
total body retinol pool size of 234 ± 158 mg (817 ± 550 µmol) using the [
13
C2]-RID test. A mean liver 
retinol concentration of 132 ± 92 µg/g (0.46 ± 0.32 µmol/g) was derived. Participants consumed a 
study diet providing 175 µg (0.6 µmol) RAE/day for 12 weeks. For the middle six weeks (day 14 to 
day 56), women were randomised to take a daily supplement of 0, 175 µg or 525 µg retinol as retinyl 
palmitate. No significant changes in liver retinol concentration and total body retinol pool size 
between and within groups were found after the intervention.  
The Panel notes that current data on the dose–response relationship between vitamin A intake and 
liver stores are limited and difficult to compare owing to differences in the vitamin A status of the 
study populations and in study designs. The Panel also notes uncertainties related to the quantitative 
total body pool and liver store estimates derived from the stable isotope dilution methods, owing to the 
different assumptions made, and uncertainties related to vitamin A intake estimates inherent to the 
dietary assessment methods used and the conversion of provitamin A carotenoids into RE. Despite 
these uncertainties, the Panel notes that two studies (Ribaya-Mercado et al., 2004; Valentine et al., 
2013) suggest that the amount of dietary vitamin A required to achieve a target liver retinol 
concentration of 20 µg/g (0.07 µmol/g) may be lower than previously calculated on the basis of the 
equation proposed by Olson (1987). 
The Panel considers that the available data from stable isotope methods are insufficient to derive the 
requirement for vitamin A for adults. 
5.2. Indicators of vitamin A requirement in pregnancy and lactation 
During pregnancy there is an additional need of vitamin A for the fetus and possibly for the growth of 
maternal tissues. However, data are scarce.  
Based on data from Thai fetuses of healthy mothers with an average retinol content in the liver of 
1 800 µg (6 µmol) at 37–40 gestational weeks (n = 10) (Montreewasuwat and Olson, 1979) and 
assuming that the liver contains approximately half of the body’s retinol content when liver stores are 
low, as is the case for newborns, a total amount of retinol of 3 600 µg (12 µmol) in the fetus was 
estimated by IOM (2001).  
There is no information on the amount of retinol accumulated in maternal tissue formed during 
pregnancy. 
With respect to lactating women, the Panel estimated a retinol secretion of 424 µg/day in breast milk 
during the first six months of lactation (Section 2.3.6.3). As discussed by Allen and Haskell (2001), 
liver stores at birth are low and sufficient to supply the infant’s vitamin A requirement for only a few 
days, even when the mother is well nourished during pregnancy. Allen and Haskell (2001) assumed 
that an intake of about 300 μg retinol/day is required to accumulate adequate liver stores during the 
first six months of life, although analytical data to support this are lacking. 
The Panel considers that data on whole body retinol stores in the fetus and on retinol secretion in 
breast milk can be used to derive the additional requirement for, respectively, pregnant or lactating 
women. 
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5.3. Vitamin A intake and health consequences 
A comprehensive search of the literature published between 1 January 1990 and 1 July 2011 was 
performed as preparatory work to identify relevant health outcomes on which DRVs for vitamin A 
may be based (Heinonen et al., 2012). Additional literature searches were performed until October 
2014. 
A number of intervention studies in children have assessed the effect of vitamin A supplementation on 
the risk of (premature) death, and the incidence and severity of diarrhoea, measles and lower 
respiratory tract infections (Fawzi et al., 1992; Anonymous, 1993; Beaton et al., 1993; Glasziou and 
Mackerras, 1993; Grotto et al., 2003; Brown and Roberts, 2004; Wu et al., 2005; Chen et al., 2008; 
Imdad et al., 2011; Mayo-Wilson et al., 2011; McLaren and Kraemer, 2012). In adults, intervention 
studies have investigated the effect of supplementation with retinol, often in combination with other 
nutrients, for the primary prevention of a variety of diseases, including cancer of various sites 
(Bjelakovic et al., 2006; Bjelakovic et al., 2008; Misotti and Gnagnarella, 2013) and reproduction-
related outcomes (Thorne-Lyman and Fawzi, 2012), and in relation to all-cause mortality (Fortmann et 
al., 2013; Bjelakovic et al., 2014). The Panel notes that these studies typically used high doses of 
vitamin A (1 000–60 000 µg RE in daily or bolus doses) and that background vitamin A intake was 
not assessed in these studies. The Panel considers that these intervention studies cannot be used for the 
setting of DRVs for vitamin A. 
The relationship between vitamin A intake and health outcomes has been investigated in observational 
(case–control, cross-sectional, prospective cohort) studies, in which an association between vitamin A 
intake and a health outcome might be confounded by uncertainties inherent in the methodology used 
for the assessment of vitamin A intake, and by the effect of other dietary, lifestyle, or undefined 
factors on the disease outcomes investigated. The Panel notes that different definitions of “vitamin A” 
have been applied among studies (i.e. defined as retinol only or as retinol and provitamin A 
carotenoids expressed in IU, µg RE or µg RAE, or undefined).  
No association was observed between retinol intake and all-cause or cardiovascular disease mortality 
in a cohort study in the UK (Fletcher et al., 2003), or between intake of “vitamin A” or retinol and risk 
of death from coronary heart disease in the prospective Iowa Women’s Health study (Kushi et al., 
1996).  
Several studies reported on the association between intake of “vitamin A” or retinol and risk of cancer 
at various sites, including risk of oral premalignant lesions (one prospective cohort study (Maserejian 
et al., 2007)), nasopharyngeal carcinoma (one case–control study (Hsu et al., 2012)), lung cancer (two 
prospective cohort studies (Yong et al., 1997; Takata et al., 2013)), benign proliferative epithelial 
disorders of the breast (one case–control study (Rohan et al., 1990); one nested case–control study 
(Rohan et al., 1998)), breast cancer (one meta-analysis (Fulan et al., 2011)), gastric cancer (two 
prospective cohort studies (Larsson et al., 2007; Miyazaki et al., 2012)), pancreatic cancer (two case–
control studies (Zablotska et al., 2011; Jansen et al., 2013)), colorectal cancer (three case–control 
studies (Key et al., 2012; Wang et al., 2012; Leenders et al., 2014); one prospective cohort study 
(Ruder et al., 2011); one systematic review (Xu et al., 2013)), prostate cancer (one case–control study 
(Ghadirian et al., 1996); one prospective cohort study (Giovannucci et al., 1995)), cervical cancer (two 
systematic reviews (Garcia-Closas et al., 2005; Zhang et al., 2012); one prospective cohort study 
(Gonzalez et al., 2011)), ovarian cancer (one case–control study (Zhang et al., 2004); one prospective 
cohort study (Fairfield et al., 2001)), bladder cancer (one case–control study (Garcia-Closas et al., 
2007)), melanoma or basal cell carcinoma (one case–control study (Naldi et al., 2004); three 
prospective cohort studies (Fung et al., 2002; Feskanich et al., 2003; Asgari et al., 2012)) and non-
Hodgkin’s lymphoma (one case–control study (Mikhak et al., 2012); one prospective cohort study 
(Kabat et al., 2012)). Results were limited and/or inconsistent. 
Some observational studies have assessed the association between “vitamin A” or retinol intake and 
asthma, wheeze or other measures of lung function with inconsistent results (a systematic review 
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including two prospective cohort studies, one nested case–control study, ten case–control studies and 
six cross-sectional studies (Allen et al., 2009); a systematic review including two case–control and 
three cross-sectional studies (Nurmatov et al., 2011); a prospective cohort study (Maslova et al., 
2014)).  
Some observational studies investigated the association between “vitamin A” or retinol intake and eye 
health-related outcomes, including cataract (one cross-sectional study (Cumming et al., 2000); one 
prospective study (Chasan-Taber et al., 1999)), age-related maculopathy (one cross-sectional study 
(Smith et al., 1999)) and age-related macular degeneration (one case–control study (Seddon et al., 
1994)) and glaucoma (one cross-sectional study (Giaconi et al., 2012); two cohort studies (Kang et al., 
2003; Ramdas et al., 2012)). Results were limited and/or inconsistent. 
In view of the limited and/or inconsistent evidence on an association between vitamin A or retinol 
intake and these health outcomes, the Panel considers that the data available cannot be used for setting 
DRVs for vitamin A.  
6. Data on which to base Dietary Reference Values 
The Panel expresses DRVs for vitamin A in µg RE/day (Section 2.3.8). The requirement of vitamin A 
can be met with any mixture of preformed vitamin A and provitamin A carotenoids that provides an 
amount of vitamin A equivalent to the reference value in terms of µg RE/day. 
6.1. Adults  
The Panel determines the AR for vitamin A in healthy adults as the vitamin A intake required to 
maintain a liver retinol concentration of 20 µg/g (0.07 µmol/g). The latter is considered by the Panel as 
indicative of an adequate vitamin A status (or vitamin A body pool) at which the different functions of 
vitamin A in the body can be fulfilled (Sections 2.4.1, 2.4.4 and 5.1.3). 
In the absence of a better characterisation of the relationship between dietary intake of vitamin A and 
liver stores, the requirement to maintain a concentration of 20 µg retinol/g liver (0.07 µmol/g) can be 
calculated on the basis of the factorial approach as proposed by Olson (1987), as follows:  
AR (µg RE/day) = target liver concentration (µg retinol/g) × body/liver retinol stores 
ratio × liver/body weight ratio (%) × fractional catabolic rate of retinol (%) × (1/efficiency of body 
storage (%)) × reference body weight (kg) × 10
3 
The Panel uses the following values for adults (Section 5.1.3.1): (1) a total body/liver retinol store 
ratio of 1.25 (i.e. 80 % of vitamin A in the body is stored in the liver); (2) a liver/body weight ratio of 
2.4 %; (3) a fractional catabolic rate of retinol of 0.7 % per day; and (4) an efficiency of storage in the 
whole body of ingested retinol of 50 %. Reference body weights for adult women and men in the EU 
are 58.5 and 68.1 kg, respectively (EFSA NDA Panel, 2013).  
On the basis of this calculation, ARs of 570 µg RE/day for men and 490 µg RE/day for women are 
derived after rounding.  
Assuming a CV of 15 % because of the variability in requirement and of the large uncertainties in the 
dataset (see Section 5.1.3.1), PRIs of 750 µg RE/day for men and 650 µg RE/day for women are set. 
PRIs were rounded to the closest 50 or 100. 
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Table 5:  Dietary Reference Values for vitamin A for men and women 
Reference body weight 
(a)
 (kg) AR (µg RE/day) 
(b)
 PRI (µg RE/day) 
(c)
 
Men Women Men Women Men Women 
68.1 58.5 570 490 750 650 
(a): Median body weight of 18- to 79-year-old men and women, respectively, based on measured body heights of 16 500 
men and 19 969 women in 13 EU Member States and assuming a body mass index (BMI) of 22 kg/m2; see Appendix 11 
in EFSA NDA Panel (2013)).  
(b): Values for ARs were rounded to the closest 10. 
(c): Values for PRIs were rounded to the closest 50, but PRIs were calculated based on the unrounded ARs. 
6.2. Infants and children 
Breast milk retinol concentration is influenced by maternal vitamin A status, and large variation in 
mean total retinol concentration of mature breast milk is observed (Section 2.3.6.3). Using estimated 
retinol intakes in exclusively breast-fed infants as a basis for setting a DRV for infants aged 7–11 
months is therefore associated with considerable uncertainty. Thus, the Panel considers it more 
appropriate to derive DRVs for infants aged 7–11 months on the same basis as for adults.  
For infants aged 7–11 months and children, the average intake of vitamin A required to maintain a 
concentration of 20 µg retinol/g liver is calculated with the same equation as for adults but with values 
for reference body weight and liver/body weight ratio specific to infants and children (Section 5.1.3.1). 
Although there is some indication that the fractional catabolic rate of retinol may be higher in children 
than in adults, data are limited (Section 2.3.6.1). In the absence of more robust data, the Panel decides 
to apply the value for fractional catabolic rate observed in adults and to correct it on the basis of a 
growth factor (Section 5.1.3.1).  
This approach is preferred to scaling down from adults based on body weight (either isometric or 
allometric), as retinol is mainly stored in the liver, the size of which does not linearly change with 
body weight during growth, and as vitamin A requirement is not directly related to energy needs and 
expenditure.  
The requirement to maintain a concentration of 20 µg retinol/g liver can be calculated in infants and 
children on the basis of the factorial approach as follows: 
AR (µg RE/day) = target liver concentration (µg retinol/g) × body/liver retinol stores 
ratio × liver/body weight ratio (%) × fractional catabolic rate of retinol (%) × (1/efficiency of body 
storage (%)) × reference body weight (kg) × (1 + growth factor) × 10
3 
The Panel uses the following values for infants aged 7–11 months and children (Section 5.1.3.1): (1) a 
total body/liver retinol stores ratio of 1.25 (i.e. 80 % of retinol in the body is stored in the liver); (2) an 
age-specific liver/body weight ratio; (3) a fractional catabolic rate of retinol of 0.7 % per day; (4) an 
efficiency of storage in the whole body of ingested retinol of 50 %; and (5) a growth factor of 0.57 for 
infants aged 7–11 months, 0.25 for boys and girls aged 1–3 years, 0.06 for boys and girls aged 4–6 
years, 0.13 for boys and girls aged 7–10 years, 0.11 for boys and 0.08 for girls aged 11–14 years, and 
0.08 for boys and 0.03 for girls aged 15–17 years (EFSA NDA Panel, 2014a). 
It was considered unnecessary to give sex-specific values for infants and children up to 14 years of 
age. As for adults, a CV of 15 % is used for setting PRIs for the respective age groups (Table 6). PRIs 
were rounded to the closest 50 or 100. 
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Table 6:  Dietary Reference Values for vitamin A for infants and children 
Age Reference body 
weight (kg) 
Liver weight (% 
body weight)  
Growth factor AR 
(h)
 
(µg RE/day) 
PRI 
(i)
 
(µg RE/day) 
7–11 months 8.6 (a) 4.0 0.57 190 250 
1–3 years 11.9 (b) 4.0 0.25 205 250 
4–6 years 19.0 (c) 3.5 0.06 245 300 
7–10 years 28.7 (d) 2.8 0.13 320 400 
11–14 years 44.6 (e) 2.8 0.11 (M) / 0.08 (F) 480 600 
15–17 years (M) 64.1 (f) 2.4 0.08 580 750 
15–17 years (F) 56.4 (g) 2.4 0.03 490 650 
AR, Average Requirement; PRI, Population Reference Intake; F, females; M, males. 
(a): Mean of the body weight-for-age at 50th percentile of male or female infants aged nine months according to the WHO 
Growth Standards (WHO Multicentre Growth Reference Study Group, 2006).  
(b): Mean of body weight-for-age at 50th percentile of boys and girls aged 24 months (WHO Multicentre Growth Reference 
Study Group, 2006). 
(c): Mean of body weight at 50th percentile of boys and girls aged 5 years (van Buuren et al., 2012). 
(d): Mean of body weight at 50th percentile of boys and girls aged 8.5 years (van Buuren et al., 2012). 
(e): Mean of body weight at 50th percentile of boys and girls aged 12.5 years (van Buuren et al., 2012). 
(f): Body weight at 50th percentile of boys aged 16 years (van Buuren et al., 2012). 
(g): Body weight at 50th percentile of girls aged 16 years (van Buuren et al., 2012). 
(h): Values for ARs were rounded to the closest 5 or 10. 
(i): Values for PRIs were rounded to the closest 50 or 100, but PRIs were calculated based on the unrounded ARs. 
6.3. Pregnancy  
The Panel assumes that a total amount of 3 600 µg retinol is accumulated in the fetus over the course 
of pregnancy (Section 5.2). Considering that the accretion mostly occurs in the last months of 
pregnancy, and assuming an efficiency of storage of 50 % for the fetus, an additional daily 
requirement of 51 µg RE is calculated for the second half of pregnancy (i.e. 3 600 µg/140 days × 2). In 
order to allow for the extra need related to the growth of maternal tissues (e.g. placenta), the Panel 
applies this additional requirement to the whole period of pregnancy. 
Consequently, an AR of 540 µg RE/day is estimated for pregnant women by adding the additional 
requirement of pregnancy to the AR for non-pregnant non-lactating women and rounding. Considering 
a CV of 15 % and rounding to the closest 100, a PRI of 700 µg RE/day is derived for pregnant women. 
6.4. Lactation  
Based on an average amount of retinol secreted in breast milk of 424 μg/day (Section 2.3.6.3) and an 
absorption efficiency of retinol of 80 % (Section 2.3.1.1), an additional vitamin A intake 
of 530 µg RE/day is considered sufficient to replace these losses. An AR of 1 020 μg RE/day is 
estimated by adding the additional requirement of lactation to the AR for non-pregnant non-lactating 
women. Considering a CV of 15 % and rounding to the closest 100, a PRI of 1 300 μg RE/day is 
proposed for lactating women.  
CONCLUSIONS 
The Panel concluded that ARs and PRIs for vitamin A in healthy adults can be derived from the 
vitamin A intake required to maintain a concentration of 20 µg retinol/g liver (0.07 µmol/g). In the 
absence of a better characterisation of the relationship between dietary intake of vitamin A and liver 
stores, ARs for adults were calculated on the basis of a factorial approach which takes into account the 
ratio of total body/liver retinol stores, the fractional catabolic rate of retinol and the efficiency of 
storage of ingested retinol. For infants aged 7–11 months and children, ARs were derived on the basis 
of the same equation as for adults, by using specific age-related values for reference body weight and 
liver/body weight ratio. For catabolic rate, the value for adults corrected on the basis of a growth 
factor was used. It was considered unnecessary to give sex-specific values for infants and children up 
to 14 years of age. The estimated amount of retinol accumulated in the fetus over the course of 
pregnancy was used as a basis to increase the AR for pregnant women. For lactating women, an 
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increase in the AR was based on the vitamin A intake required to compensate for the amount of retinol 
secreted in breast milk. Owing to the variability in requirement and the large uncertainties in the 
dataset, a CV of 15 % was used to calculate PRIs for all population groups (Table 7). 
Table 7:  Summary of Population Reference Intakes for vitamin A 
Age Population Reference Intake 
(µg/day) 
7–11 months   250 
1–3 years   250 
4–6 years   300 
7–10 years   400 
11–14 years   600 
15–17 years (M)   750 
15–17 years (F)   650 
≥ 18 years (M)    750 
≥ 18 years (F)   650 
Pregnancy   700 
Lactation 1 300 
F, females; M, males. 
RECOMMENDATIONS FOR RESEARCH 
The Panel recommends the following actions:  
 pursue the characterisation of provitamin A carotenoid bioconversion to retinol;  
 pursue the development of indirect measurement of liver stores by stable isotope dilution methods 
and application of the method to inform the dose–response relationship between vitamin A intake 
and retinol liver stores; 
 further investigate and characterise the fractional catabolic rate of retinol and its determinants, 
including the influence of hepatic retinol stores, age and physiological state (e.g. pregnancy); 
 characterise the efficiency of storage of a physiological dose of retinol in populations with 
adequate status; 
 undertake research regarding the vitamin A requirement of infants and children; 
 further characterise the relationship between vitamin A intake and health effects across the range 
of dietary intakes;  
 further investigate the genetic basis of the differences in efficiency in provitamin A carotenoid and 
retinol metabolism in humans. 
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APPENDICES 
Appendix A.  Prospective cohort and nested case–control studies on the association between intake of “vitamin A” and retinol and risk of bone 
fracture 
Reference Design Study sample Dietary assessment Outcomes Daily intake of vitamin A 
(µg RE/day) (a) and retinol 
(µg/day) 
Other factors 
considered in the 
analysis 
Results 
Melhus et al. 
(1998) (b) (c) 
Nested case–
control study 
within the 
Swedish 
Mammography 
Cohort 
1 120 women, aged 
40–76 years, in 
Sweden; 247 
cases/873 controls 
One FFQ covering the 
previous six months 
performed at baseline. 
No information on 
inclusion of 
supplements 
Incidence of hip 
fracture. Hospital 
discharge records 
Mean ± SD (range) of retinol 
intake 
Cases: 960 ± 480 (260–
3 210) µg 
Controls: 880 ± 430 (260–
5 510) µg 
Energy intake, BMI, age 
at menopause, lifetime 
physical activity, 
smoking status, 
hormone replacement 
therapy, diabetes 
mellitus, oral 
contraceptive or 
cortisone use, previous 
osteoporotic fracture, 
intake of iron, 
magnesium, vitamin C, 
and calcium 
Retinol 
Multivariate OR = 2.05 
(95 % CI = 1.05–3.98) with a 
retinol intake >1 500 μg/day 
(highest category) compared 
with ≤ 500 μg/day (lowest 
category) 
p for trend = 0.006 
 
β-Carotene 
No association found (data not 
shown) 
Feskanich et 
al. (2002) (b) 
(c) 
Prospective 
study, 18 years’ 
follow-up  
(Nurses’ Health 
Study, 1980–
1998) 
72 337 
postmenopausal 
women aged 34–77 
years in the USA 
Semi-quantitative FFQ 
performed five times 
over study duration. 
Mean intake value 
determined from the 
mean of the five FFQs. 
Retinol and carotenoid 
content of foods from 
US Department of 
Agriculture and 
National Cancer 
Institute sources. Use 
of brand-specific 
supplements included 
Incidence of hip 
fracture. Self-
reported by 
questionnaire every 
two years 
Quintiles of vitamin A 
From food only 
(n = 34 386, excluding 
supplement users)  
Q1: < 1 000; Q2: 1 000–
1 299; Q3: 1 300–1 599; Q4: 
1 600–1 999; Q5: ≥ 2 000 
µg RE 
From food and supplements 
(n = 72 337)  
Q1: < 1 250; Q2: 1250–
1 699; Q3: 1 700–2 249, Q4: 
2 250–2 999; Q5: ≥ 3 000 µg 
RE 
 
Quintiles of retinol intake 
From food only 
(n = 34 386, excluding 
supplement users)  
Q1: < 400; Q2: 400–549; Q3: 
Age, follow-up cycle, 
intake of calcium, 
vitamin D, vitamin K, 
protein, alcohol and 
caffeine, smoking 
status, number of 
cigarettes smoked per 
day, use of 
postmenopausal 
hormones, body weight, 
hours of physical 
activity a day, use of 
thiazide diuretics 
Vitamin A 
Food only (excluding 
supplement users) 
No association (multivariate 
RR). 
Food and supplements 
Multivariate RR = 1.48 
(95 % CI = 1.05–2.07) with a 
vitamin A intake ≥ 3 000 µg 
RE/day (Q5) compared with 
< 1 250 µg RE/day (Q1) 
p for trend = 0.003 
 
Retinol  
Food only (excluding 
supplement users) 
Multivariate RR = 1.69 
(95 % CI = 1.05–2.74) with a 
retinol intake ≥ 1 000 µg/day 
(Q5) compared with 
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Reference Design Study sample Dietary assessment Outcomes Daily intake of vitamin A 
(µg RE/day) (a) and retinol 
(µg/day) 
Other factors 
considered in the 
analysis 
Results 
550–699; Q4: 700–999; Q5: 
≥ 1 000 µg 
From food and supplements 
(n = 72 337)  
Q1: < 500; Q2: 500–849; Q3: 
850–1 299; Q4: 1 300–1 999; 
Q5: ≥ 2 000 µg 
< 400 µg/day (Q1) 
p for trend = 0.05 
Food and supplements 
Multivariate RR = 1.89 
(95 % CI = 1.33–2.68) with a 
retinol intake ≥ 2 000 µg/day 
(Q5) compared to < 500 µg/day 
(Q1) 
Multivariate RR = 1.43 
(95 % CI = 1.04–1.96) with a 
retinol intake of 1 300–
1 999 µg/day (Q4) compared 
with < 500 µg/day (Q1) 
p for trend = < 0.001 
 
β-Carotene 
No association (multivariate 
RR) 
Michaelsson 
et al. 
(2003) (c) 
Prospective 
study, 30 years’ 
follow-up 
1 221 men, aged 
49–51 years, in 
Sweden 
Seven-day dietary 
assessment, 20 years 
after entry into study. 
Food composition from 
Swedish National Food 
Administration 
database. Use of brand-
specific supplements 
included 
Incidence of any 
fracture. Hospital 
discharge register 
Not provided Energy intake Retinol 
Food only  
Rate ratio (energy-adjusted) = 
2.00 (95 % CI = 1.00–3.99) for 
any fracture with retinol intake 
> 1 500 μg/day (Q5) compared 
to < 530 µg/day (Q1). 
Food and supplements 
Rate ratio (energy-adjusted) = 
1.99 (95 % CI = 0.98–4.01) for 
any fracture for Q5 (no value 
reported) vs. Q1 (no value 
reported) 
Lim et al. 
(2004) (c) 
Prospective 
study, 9.5 years’ 
follow-up (Iowa 
Women’s Health 
Study 1986–
1997) 
34 703 
postmenopausal 
women, aged 55–
69 years, in the 
USA 
One semi-quantitative 
FFQ performed at 
baseline. Use of brand-
specific supplements 
included 
Incidence of hip 
and non-hip 
fracture. Self-
reported by 
questionnaire at the 
end of the follow- 
up period 
Mean (range) for each 
quintile of vitamin A intake 
(in IU) 
From food only (n = 22 410, 
excluding supplement users) 
Q1: 4 440 (221–5 975); Q2: 
7 223 (5 976–8 544); Q3: 
10 043 (8 545–11 699); Q4: 
For hip fracture 
Age, BMI, waist-to-hip 
ratio, diabetes mellitus, 
physical activity, 
occurrence of past 
irregular menstrual 
duration, steroid 
medication, oestrogen 
Vitamin A and retinol 
No association (multivariate 
RR) between vitamin A or 
retinol intake, from supplements 
only, food and supplements, or 
food only (excluding 
supplement users), and risk of 
hip fracture or risk of all 
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Reference Design Study sample Dietary assessment Outcomes Daily intake of vitamin A 
(µg RE/day) (a) and retinol 
(µg/day) 
Other factors 
considered in the 
analysis 
Results 
13 793 (11 700–16 431); Q5: 
24 163 (16 432–215 392) IU 
From food and supplements 
(n = 34 703) 
Q1: 5 113 (221–7 055); Q2: 
8 771 (7 056–10 484); Q3: 
12 256 (10 485–14 209); Q4: 
16 764 (14 210–19 892); Q5: 
29 239 (19 893–236 991) IU 
 
Mean (range) for each 
quintile of retinol intake 
From food only (n = 22 410, 
excluding supplement users) 
Q1: 744 (28–1 086); Q2: 
1 424 (1 087–1 790); Q3: 
2 356 (1 791–3 260); Q4: 
3 967 (3 261–4 660); Q5: 
6 878 (4 661–209 573) IU 
From food and supplements 
(n = 34 703) 
Q1: 912 (28–1405); Q2: 
2 031 (1 406–2 952); Q3: 
3 857 (2 953–4 655); Q4: 
5 768 (4 656–7 001); Q5: 
1 2 610 (7 002–211 051) IU 
replacement, energy 
intake 
 
For all fractures 
Age, BMI, waist-to-hip 
ratio, diabetes mellitus, 
cirrhosis, past irregular 
menstrual duration, 
thyrotropic, sedative, 
antiepileptic or diuretic 
medications, education, 
alcohol use and energy 
intake 
fractures 
Rejnmark et 
al. (2004) 
Nested case–
control study 
1 141 
perimenopausal 
women aged 45–58 
years in Denmark; 
163 cases/978 
controls 
Four- or seven-day 
food record at baseline 
and after five years. 
Composition data from 
official Danish food 
tables. Use of 
supplements included 
Incidence of 
fractures. Self-
reported, confirmed 
by hospital 
discharge records 
Median (interquartile range) 
of vitamin A intake 
From food only 
Cases: 1 150 (730–1 720) 
µg RE 
Controls: 1 140 (800–1 660) 
µg RE 
From food and supplements 
Cases: 1 730 (1 280–2 380) 
µg RE 
Controls: 1 710 (1 290–
2 260) µg RE 
 
 Vitamin A, retinol and β-
carotene 
No association (multivariate 
OR) between vitamin A, retinol 
or β-carotene intake, from food 
only or food and supplements, 
and risk of fracture 
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Reference Design Study sample Dietary assessment Outcomes Daily intake of vitamin A 
(µg RE/day) (a) and retinol 
(µg/day) 
Other factors 
considered in the 
analysis 
Results 
Median (interquartile range) 
of retinol intake 
From food only 
Cases: 510 (350–700) µg 
Controls: 520 (380–740) µg 
From food and supplements 
Cases: 1 190 (700–1 420) µg 
Controls: 1 210 (740–
1 430) µg 
Caire-
Juvera et al. 
(2009) 
Prospective 
study. 6.6 years’ 
follow-up 
(Women’s 
Health Initiative 
Observational 
Study 1993–
2005) 
75 747 
postmenopausal 
women, mean age 
at baseline 
63.6 years, in the 
USA 
FFQ at baseline and at 
three-year follow-up. 
Mean intake value 
determined from the 
mean of the two FFQs. 
Retinol and carotenoid 
content of foods from 
the University of 
Minnesota Nutrition 
Coding Center nutrient 
database. Use of brand-
specific supplements 
included 
Incidence of hip 
and non-hip 
fracture. 
Questionnaire 
every year from 
participants or 
proxy respondents. 
Hip fractures were 
confirmed by 
medical records 
Quintiles of vitamin A 
From food and supplements 
Q1: < 5 055; Q2: 5 055–
5 824; Q3: 5 825–6 550; Q4: 
6 551–7 507; Q5: ≥ 7 508 µg 
RE 
 
Mean ± SD intake of retinol, 
for each quintile of vitamin A 
intake 
From food and supplements 
Q1: 412 ± 187; Q2: 727 ± 
284; Q3: 983 ± 341; Q4: 
1 227 ± 407; Q5: 1 968 ± 
1 266 µg 
Age, intake of protein, 
vitamin D, vitamin K, 
calcium, caffeine, and 
alcohol, BMI, hormone 
therapy, smoking, 
metabolic equivalents 
hours per week, 
ethnicity and region of 
clinical centre 
Vitamin A and retinol 
No association (multivariate 
HR, including vitamin D and 
calcium) between vitamin A 
intake or retinol, from food and 
supplements, and risk of hip 
fracture or risk of total fracture 
 
Among the women with lower 
vitamin D intake (≤ 11 µg/day), 
there was a higher risk of total 
fractures in Q5 of vitamin A 
intake (mean 8 902 µg RE/day) 
compared with Q1 (mean 
4 445 µg RE/day) (HR: 1.19; 
95 % CI = 1.04–1.37; p for 
trend = 0.022) and in Q5 of 
retinol intake (mean 
2 488 µg/day) compared with 
Q1 (mean 348 µg/day) (HR: 
1.15; 95 % CI = 1.03–1.29; p for 
trend = 0.056). Given the 
smaller number of hip fractures, 
stratified analysis by vitamin D 
and calcium intake was not 
conducted 
Ambrosini 
et al. (2013) 
Retrospective 
analysis of the 
Vitamin A 
Program 
664 women and 
1 658 men in 
Australia (99 % 
participants on the 
Background dietary 
intake not assessed. 
Supplementation with 
7 500 µg/day of retinol 
Database on 
hospital admissions 
for fracture and 
self-reported by 
Background dietary intake 
not reported. Cumulative 
dose of retinol supplements 
was estimated by summing 
Age, sex, smoking, 
BMI, medication use 
and previous fractures 
Retinol 
No associations (multivariate 
OR) between cumulative dose 
of retinol and risk for any 
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Reference Design Study sample Dietary assessment Outcomes Daily intake of vitamin A 
(µg RE/day) (a) and retinol 
(µg/day) 
Other factors 
considered in the 
analysis 
Results 
Vitamin A 
Program), mean 
age at enrolment 
55 years 
as retinyl palmitate for 
1–16 years (median 7 
years) 
questionnaire sent 
to all surviving 
programme 
participants after 
the end of the 
intervention. Self-
reported fractures 
occurring at the 
spine, hip, femur, 
arm, ribs or wrist 
were classified as 
osteoporotic 
fractures 
the number of days the 
supplement was taken 
between each annual follow-
up, multiplying by the dose 
administered and adding to 
the previous year’s total. 
Cumulative doses of retinol 
were analysed in units of 
10 g. The maximum 
cumulative dose of retinol 
was 42 g, equivalent to 
taking 7 500 µg/day for 15.3 
years 
fracture or osteoporotic fracture 
BMI, body mass index; CI, confidence interval; FFQ, food frequency questionnaire; HR, hazard ratio; OR, odds ratio; Q, quintile; RR, relative risk; IU, International Unit. 
(a): Unless stated otherwise. 
(b): Study considered in SCF (2002). 
(c): Study considered in SACN (2005). 
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Appendix B.  Intervention and prospective cohort studies on the association between intake of “vitamin A” and retinol and measures of bone 
mineral content (BMC), bone mineral density (BMD) or serum markers of bone turnover 
Reference Design Study sample Dietary 
assessment 
Outcomes Daily intake of vitamin 
A (µg RE/day) (a) and 
retinol (µg/day) 
Other factors 
considered in the 
analysis 
Results 
Measures of BMC, BMD 
Freudenheim et 
al. (1986) (b) (c) 
Prospective study, 
four years’ follow-
up within a 
calcium 
supplementation 
trial 
99 pre-  and 
postmenopausal women, 
aged 35–65 years, in the 
USA 
Seventy-two 24-
hour dietary 
records 
collected for 
each participant 
over three years, 
including 
supplements. 
Subjects were 
assigned to a 
500 mg 
calcium-
supplemented or 
a placebo group 
BMC of left arm 
bones (radius, 
humerus and 
ulna). 
By SPA. 
Eleven 
measurements, 
every three 
months for the 
first year and 
then every six 
months 
Mean ± SD (range) 
“vitamin A” (d) intake 
from food and 
supplements (in IU) 
Postmenopausal calcium 
unsupplemented (n = 33) 
8 624 ± 3 553 (3 615–
17 763) IU 
Calcium supplemented (n 
= 34) 
7 619 ± 2 729 (3 256–
14 624) IU 
None. “Vitamin A” (d) 
In the postmenopausal calcium-
supplemented group, there was a 
negative correlation between 
“vitamin A” intake and rate of 
change in ulna BMC – the 
correlation was not significant 
when one subject with very high 
supplemental “vitamin A” intake 
was omitted. No correlation was 
observed in the postmenopausal 
calcium-unsupplemented group 
 
There were no correlations in the 
groups of calcium-supplemented 
(n = 8) and calcium-
unsupplemented (n = 9) 
premenopausal women 
Houtkooper et 
al. (1995) (b) (c) 
One year follow-up 
within a physical 
exercise trial 
66 premenopausal 
women, aged 28–39 
years, in the USA 
Dietary records 
over 4–12 
randomly 
assigned days. 
Vitamin 
supplements not 
included. All 
subjects were 
administered a 
500-mg calcium 
supplement 
BMD of total 
body, lumbar 
vertebrae 2-4, 
femoral neck, 
Ward’s triangle, 
trochanter. 
By DXA. 
Four 
measurements, at 
baseline and 
months 5, 12 and 
18 
Mean ± SD “vitamin 
A” (d) 
From food only 
1 220 ± 472 μg RE 
Fat mass at 
baseline and 
change in fat mass 
over one year, 
exercise status. 
“Vitamin A” (d) 
Significant variables in models 
predicting total body BMD slope 
included initial fat mass and fat 
mass slope plus either “vitamin 
A” (d) intake (R2 = 0.31) or β-
carotene intake (R2 = 0.28) 
Promislow et al. 
(2002) (c) 
Prospective study, 
with four years’ 
follow-up, within 
the Ranchi 
570 women and 388 men, 
aged 55–92 years at 
baseline, in the USA 
FFQ at baseline. 
Supplement use 
included 
BMD of total hip, 
femoral neck, 
lumbar spine. By 
DXA. Two 
Mean ± SD of retinol 
intake 
From food only 
Women: 497 ± 460 μg 
Age, weight 
change, BMI, 
calcium intake, 
diabetes status, 
Retinol 
No association between retinol 
intake and BMD at baseline or 
BMD change when supplement 
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Reference Design Study sample Dietary 
assessment 
Outcomes Daily intake of vitamin 
A (µg RE/day) (a) and 
retinol (µg/day) 
Other factors 
considered in the 
analysis 
Results 
Bernardo Heart and 
Chronic Disease 
Study 
measurements, 
taken at baseline 
and follow-up 
Men: 624 ± 585 μg 
From food 
and supplements 
Women: 1 247 ± 
1 573 μg 
Men: 1 242 ± 1 442 μg 
menopausal status, 
exercise, smoking 
status, alcohol use, 
thiazide drug use, 
thyroid hormone 
use, steroid use, 
oestrogen use, 
supplemental 
retinol 
users and non-users were pooled 
For supplement 
users only 
Women: a significant negative 
association was found between 
retinol intake and BMD at the 
femoral neck (p = 0.02) and total 
spine (p = 0.03) measured at 
follow-up and for BMD change at 
femoral neck (p = 0.05) and total 
hip (p = 0.02) 
Men: no significant association 
Macdonald et al. 
(2004) 
Prospective study, 
within the 
Aberdeen 
Prospective 
Osteoporosis 
Screening Study, 
5–7 years’ follow-
up 
891 women, aged 45–55 
years at baseline, in the 
UK 
FFQ at baseline 
and five years 
later. 
Composition 
data from 
McCance and 
Widdowson’s 
food 
composition 
tables. Use of 
brand-specific 
supplements 
included 
BMD of lumbar 
spine, femoral 
neck 
By DXA 
Two 
measurements, at 
baseline and 
follow-up 
Vitamin A intake 
Not reported. 
Mean ± SD (range, 
median) of retinol intake 
From food only 
Baseline: 820 ± 602 (39–
4 354, 588) μg 
Follow-up: 665 ± 513 
(70–5 237, 480) μg 
From food and 
supplements 
Baseline: 924 ± 666 (85–
4 354, 702) μg 
Follow-up: 882 ± 654 
(70–5 237, 627) μg 
Energy intake, age, 
weight, annual 
percentage change 
in weight, height, 
smoking status, 
socioeconomic 
status, physical 
activity level, 
baseline BMD 
measurement, 
menopausal status 
and hormone 
replacement 
therapy use 
Vitamin A 
In multiple regression analysis, 
vitamin A intake from food only 
was a weak but significant negative 
predictor of femoral neck BMD 
change (variation explained: 0.3 %, 
coefficient (95 % CI): –1.24 (–2.47 
to 0.17), p = 0.047). No significant 
relation when intake from 
supplements was included 
 
Retinol 
In multiple regression analysis, 
retinol intake from food only was a 
weak but significant negative 
predictor of femoral neck BMD 
change (variation explained: 0.4 %, 
coefficient (95 % CI): –1.73 (–3.20 
to –0.30), p = 0.018). No 
significant relation when intake 
from supplements was included 
Rejnmark et al. 
(2004) 
Prospective study, 
five years’ follow-
up within the 
Danish 
Osteoporosis 
Prevention Study 
1 694 perimenopausal 
women, aged 45–58 
years, in Denmark 
Four- or seven-
day food record 
at baseline and 
after five years. 
Intake at 
baseline was 
BMD of lumbar 
spine, femoral 
neck. By DXA. 
Two 
measurements, at 
baseline and five-
Median (interquartile 
range) vitamin A intake 
(baseline) 
From food only 
1 150 (800–1 730) μg RE 
From food and 
Age, years 
postmenopausal, 
hormone therapy, 
previous fracture, 
body weight, 
baseline BMD, 
Vitamin A and retinol 
Multiple regression analysis 
showed no association between 
baseline vitamin A or retinol 
intake, from food only or food and 
supplements, and change in BMD 
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Reference Design Study sample Dietary 
assessment 
Outcomes Daily intake of vitamin 
A (µg RE/day) (a) and 
retinol (µg/day) 
Other factors 
considered in the 
analysis 
Results 
considered in 
the analysis. 
Composition 
data from 
official Danish 
food tables. Use 
of supplements 
included 
year follow-up supplements 
1 740 (1 290–2 360) 
μg RE 
 
Median (interquartile 
range) retinol intake 
(baseline) 
From food only 
530 (390–750) μg 
From food and 
supplements 
1 210 (680–1 450) μg 
physical activity, 
energy intake, 
intake of calcium, 
vitamin D, alcohol, 
smoking status, use 
of thiazide or loop 
diuretics, thyroid 
hormones, 
antipsychotic/ 
anxiolytic/ 
antidepressant 
drugs, diagnosis of 
thyrotoxicosis, 
diabetes mellitus 
at any site 
 
β-Carotene 
No association between β-carotene 
intake, from food only, and change 
in BMD at any site 
Measures of serum markers of bone turnover 
Kawahara et al. 
(2002) (b) (c) 
Randomised 
single-blind trial 
lasting six weeks 
80 men, aged 18–58 
years, in the USA 
Subjects were 
assigned to 
7 576 µg retinyl 
palmitate/day or 
placebo. 
Background 
retinol intake 
not assessed 
Serum 
osteocalcin, 
bone-specific 
alkaline 
phosphatase, N-
telopeptide of 
type 1 collagen/ 
Blood sampled at 
baseline and 
weeks 2, 4 and 6 
Not reported.  Retinol 
Supplementation did not affect 
serum osteocalcin, bone-specific 
alkaline phosphatase or N-
telopeptide of type 1 collagen 
BMC, bone mineral content; BMD, bone mineral density; BMI, body mass index; CI, confidence interval; DXA, dual energy X-ray absorptiometry; FFQ, food frequency questionnaire; IU, 
International Unit; SPA, single-photon absorptiometry. 
(a): Unless stated otherwise. 
(b): Study considered in SCF (2002). 
(c): Study considered in SACN (2005). 
(d): It is unclear from the article whether it refers to vitamin A or retinol only. 
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Appendix C.  Retinol concentration in breast milk from mothers of term infants 
Reference Number of 
women  
Country Maternal vitamin A intake Stage of lactation 
(time post partum) 
Concentration (µg/L) Methods (a) 
Mean ± SD Median Range 
Canfield et al. 
(2003) 
53 Australia Not reported.  Mothers who 
were taking supplements 
containing carotenoids or 
vitamin A (> 8 000 IU/day) 
were excluded 
Mature milk (months 
2–12) 
311 ± 16 (SE)   Single complete breast expression 
by electric breast pump collected 
mid-afternoon from each mother. 
Samples were collected from the 
breast from which the infant had 
most recently fed. Samples were 
saponified before analysis of 
retinol by HPLC 
55 Canada Mature milk (months 
2–12) 
340 ± 19 (SE)   
50 UK Mature milk (months 
2–12) 
301 ± 14 (SE)   
49 USA Mature milk (months 
2–12) 
352 ± 25 (SE)   
Schweigert et al. 
(2004) 
21 Germany Not reported.  Mothers taking 
supplements containing 
carotenoids or vitamin A were 
excluded 
Colostrum (days 
4 ± 2) 
1 532 ± 725   Total milk volume of one breast 
was collected. Samples were 
saponified before analysis of 
retinol by HPLC 
21  Mature milk (days 
19 ± 2) 
831 ± 321   
Schulz et al. 
(2007) 
26 Germany Mean ± SD: 
Retinol intake: 
0.95 ± 0.64 mg/day 
Carotenoid intake: 6.9 ± 
3.6 mg/day 
Total vitamin A intake: 2.11 ± 
0.89 mg RE/day. 
By FFQ. Mothers taking 
prenatally supplements with 
> 2 000 IU/day of vitamin A or 
> 2 mg/day of -carotene were 
excluded 
Colostrum (days 1–2) 1 106 ± 851   Samples collected by hand 
expression or electric pump up to a 
volume of 4 mL, collected on one 
or more occasions. Samples were 
saponified before analysis of 
retinol by HPLC 
Tokusoglu et al. 
(2008)  
92 Turkey Not reported Mature milk (days 60–
90) 
815 ± 120.6   Milk samples (10 mL) collected 
from both breasts by hand 
expression, at least two hours after 
previous breastfeeding. Samples 
were saponified before analysis of 
retinol by HPLC 
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Reference Number of 
women  
Country Maternal vitamin A intake Stage of lactation 
(time post partum) 
Concentration (µg/L) Methods (a) 
Mean ± SD Median Range 
Duda et al. 
(2009) (b) 
30 Poland Mean ± SD:  
“vitamin A-equivalent” intake: 
1 012 ± 735 μg/day 
β-carotene intake: 2 096 ± 2 465 
μg/day 
By 24-hour recall (repeated on 
three consecutive days) 
Mature milk (months 
2–4) 
571 ± 500 294 157–1 424 Milk samples expressed by hand or 
using a sterile pump one or two 
hours prior to actual feeding of the 
baby. Samples were saponified 
before analysis of retinol by HPLC 
Orhon et al. 
(2009) 
20 Turkey Mean ± SEM: 
4 965.2 ± 538.5 IU/day 
By 5-day dietary record 
Significant correlation between 
dietary vitamin A intake and 
retinol concentration of breast 
milk (r = 0.621, p = 0.006). No 
correlation between dietary 
vitamin A intake and -carotene 
concentration in breast milk 
Transitional milk (day 
7) 
2 463 ± 200 (SE)   Milk samples (5 mL) were 
collected from each breast using an 
electric pump. Treatment of the 
samples not described. Retinol 
analysed by HPLC 
Kasparova et al. 
(2012) (b) 
12 Czech 
Republic 
Not reported Mature milk: months 
1–2  
458 ± 286   Milk samples obtained from a 
university hospital; method of 
expression not described. Samples 
were saponified before analysis of 
retinol by HPLC 
   Mature milk: months 
3–4  
315 ± 258   
   Mature milk: months 
5–6  
229 ± 115   
   Mature milk: months 
9–12  
172 ± 115   
Studies were identified by a comprehensive literature search for publications from January 2000 to January 2014 (LASER Analytica, 2014). Note that if studies did not report whether infants 
were born at term or not it was presumed that infants were born at term. 
HPLC, high-performance liquid chromatography; IU, International Unit. 
(a): Determination of total breast milk retinol requires saponification (typically with alcoholic potassium hydroxide (KOH)) and retinol is then extracted with an organic solvent, usually 
hexanes, before HPLC analysis (Tanumihardjo and Penniston, 2002). 
(b): It was not reported whether the infants were born at term or not. 
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Appendix D.  Dietary surveys in the updated EFSA Comprehensive European Food Consumption Database included in the nutrient intake 
calculation and number of subjects in the different age classes 
Country Dietary survey Year Method Days Number of subjects (a) 
Children 
1 to < 3 
years 
Children 
3 to < 10 
years 
Children 
10 to < 18 
years 
Adults 
18 to < 65 
years 
Adults 
65 to < 75 
years 
Adults 
≥ 75 
years 
Finland/1 DIPP 2000–2010 Dietary record 3 500 750     
Finland/2 NWSSP 2007–2008 48-hour dietary recall (b) 2  2 (b)   306    
Finland/3 FINDIET2012 2012 48-hour dietary recall 
(b)
 2 
(b)
    1 295 413  
France INCA2 2006–2007 Dietary record 7  482 973 2 276 264 84 
Germany/1 EsKiMo 2006 Dietary record 3  835 393    
Germany/2 VELS 2001–2002 Dietary record 6 347 299     
Ireland NANS 2008–2010 Dietary record 4    1 274 149 77 
Italy INRAN-SCAI 2005-06 2005–2006 Dietary record 3 36 (a) 193 247 2 313 290 228 
Latvia FC_PREGNANTWOMEN 2011 2011 24-hour dietary recall 2   12 
(a)
 991 
(c)
   
Netherlands DNFCS 2007–2010 2007–2010 24-hour dietary recall 2  447 1 142 2 057 173  
Sweden RISKMATEN 2010–2011 Dietary record (Web)  4    1 430 295 72 
United 
Kingdom 
NDNS - 
Rolling Programme (1–3 years) 
2008–2011 Dietary record 4 185 651 666 1 266 166 139 
DIPP, type 1 Diabetes Prediction and Prevention survey; DNFCS, Dutch National Food Consumption Survey; EsKiMo, Ernährungstudie als KIGGS-Modul; FINDIET, the national dietary 
survey of Finland; INCA, étude Individuelle Nationale de Consommations Alimentaires; INRAN-SCAI, Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione—Studio sui Consumi 
Alimentari in Italia; FC_PREGNANTWOMEN, food consumption of pregnant women in Latvia; NANS, National Adult Nutrition Survey; NDNS, National Diet and Nutrition Survey; NWSSP, 
Nutrition and Wellbeing of Secondary School Pupils; VELS, Verzehrsstudie zur Ermittlung der Lebensmittelaufnahme von Säuglingen und Kleinkindern für die Abschätzung eines akuten 
Toxizitätsrisikos durch Rückstände von Pflanzenschutzmitteln. 
(a): 5th or 95th percentile intakes calculated from fewer than 60 subjects require cautious interpretation as the results may not be statistically robust (EFSA, 2011b) and, therefore, for these 
dietary surveys/age classes, the 5th and 95th percentile estimates will not be presented in the intake results. 
(b): A 48-hour dietary recall comprises two consecutive days. 
(c): One subject was excluded from the dataset because only one 24-hour dietary recall day was available, i.e. final n = 990. 
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Appendix E.  Vitamin A intake in males in different surveys according to age classes and country (µg RE/day) 
Age class Country Survey n Average P5 P50 P95 
1 to < 3 years Finland DIPP_2001_2009 245 491 116 419 1 134 
 
Germany VELS 174 651 264 582 1 294 
 
Italy INRAN_SCAI_2005_06 20 554 
(a) 
499 
(a) 
 
United Kingdom NDNS-RollingProgrammeYears1-3 107 576 260 496 1 032 
3 to < 10 years Finland DIPP_2001_2009 381 751 243 550 2 022 
 
France INCA2 239 702 240 579 1 353 
 
Germany EsKiMo 426 889 329 754 1 951 
 
Germany VELS 146 685 331 656 1 271 
 
Italy INRAN_SCAI_2005_06 94 873 293 618 1 475 
 
Netherlands DNFCS 2007–2010 231 741 204 589 1 876 
 
United Kingdom NDNS-RollingProgrammeYears1-3 326 607 245 531 1 104 
10 to < 18 years Finland NWSSP07_08 136 776 285 644 1 391 
 
France INCA2 449 758 259 635 1 475 
 
Germany EsKiMo 197 949 361 803 2 213 
 
Italy INRAN_SCAI_2005_06 108 891 360 688 1 766 
 
Netherlands DNFCS 2007–2010 566 866 249 664 2 076 
 
United Kingdom NDNS-RollingProgrammeYears1-3 340 686 236 600 1 351 
18 to < 65 years Finland FINDIET2012 585 1 078 325 867 2 154 
 
France INCA2 936 978 279 747 2 068 
 
Ireland NANS_2012 634 1 023 356 891 1 864 
 
Italy INRAN_SCAI_2005_06 1 068 984 345 750 1 924 
 
Netherlands DNFCS 2007–2010 1 023 1 097 340 858 2 662 
 
Sweden Riksmaten 2010 623 995 311 880 2 005 
 
United Kingdom NDNS-RollingProgrammeYears1-3 560 930 268 768 1 847 
65 to < 75 years Finland FINDIET2012 210 1 086 307 823 2 345 
 
France INCA2 111 1 279 367 892 5 080 
 
Ireland NANS_2012 72 1 243 360 1173 2 558 
 
Italy INRAN_SCAI_2005_06 133 1 036 353 772 2 058 
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Age class Country Survey n Average P5 P50 P95 
 
Netherlands DNFCS 2007–2010 91 1 029 316 871 2 604 
 
Sweden Riksmaten 2010 127 1 042 437 911 1 879 
 
United Kingdom NDNS-RollingProgrammeYears1-3 75 1 423 345 1077 5 360 
≥ 75 years France INCA2 40 1 057 
(a) 
794 
(a) 
 
Ireland NANS_2012 34 992 
(a) 
881 
(a) 
 
Italy INRAN_SCAI_2005_06 69 949 291 722 1 635 
 
Sweden Riksmaten 2010 42 1 270 
(a) 
1059 
(a) 
 
United Kingdom NDNS-RollingProgrammeYears1-3 56 1 353 
(a) 
798 
(a) 
n, number of individuals; P5, 5th percentile; P50, 50th percentile; P95, 95th percentile. 
DIPP, type 1 Diabetes Prediction and Prevention survey; DNFCS, Dutch National Food Consumption Survey; EsKiMo, Ernährungstudie als KIGGS-Modul; FINDIET, the national dietary 
survey of Finland; INCA, étude Individuelle Nationale de Consommations Alimentaires; INRAN-SCAI, Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione—Studio sui Consumi 
Alimentari in Italia; NANS, National Adult Nutrition Survey; NDNS, National Diet and Nutrition Survey; NWSSP, Nutrition and Wellbeing of Secondary School Pupils; VELS, Verzehrsstudie 
zur Ermittlung der Lebensmittelaufnahme von Säuglingen und Kleinkindern für die Abschätzung eines akuten Toxizitätsrisikos durch Rückstände von Pflanzenschutzmitteln. 
(a): 5th or 95th percentile intakes calculated from fewer than 60 subjects require cautious interpretation, as the results may not be statistically robust (EFSA, 2011b) and, therefore, for these 
dietary surveys/age classes, the 5th and 95th percentile estimates will not be presented in the intake results. 
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Appendix F.  Vitamin A intake in females in different surveys according to age classes and country (µg RE/day) 
Age class Country Survey n Average P5 P50 P95 
1 to < 3 years Finland DIPP_2001_2009 255 409 125 358 255 
 
Germany VELS 174 598 240 525 174 
 
Italy INRAN_SCAI_2005_06 16 446 
(a) 
428 16 
 
United Kingdom NDNS-RollingProgrammeYears1-3 78 437 182 422 78 
3 to < 10 years Finland DIPP_2001_2009 369 647 234 501 369 
 
France INCA2 243 609 230 537 243 
 
Germany EsKiMo 409 793 279 715 409 
 
Germany VELS 147 654 301 590 147 
 
Italy INRAN_SCAI_2005_06 99 696 262 592 99 
 
Netherlands DNFCS 2007–2010 216 716 203 545 216 
 
United Kingdom NDNS-RollingProgrammeYears1-3 325 610 225 576 325 
10 to < 18 years Finland NWSSP07_08 170 724 345 631 170 
 
France INCA2 524 662 217 557 524 
 
Germany EsKiMo 196 892 320 752 196 
 
Italy INRAN_SCAI_2005_06 139 799 280 680 139 
 
Latvia 
(b)
 FC_PREGNANTWOMEN_2011 12 1 078 
(a) 
970 12 
 
Netherlands DNFCS 2007–2010 576 713 236 573 576 
 
United Kingdom NDNS-RollingProgrammeYears1-3 326 597 225 518 326 
18 to < 65 years Finland FINDIET2012 710 960 312 799 710 
 
France INCA2 1 340 979 301 713 1 340 
 
Ireland NANS_2012 640 897 319 765 640 
 
Italy INRAN_SCAI_2005_06 1 245 885 322 708 1 245 
 
Latvia 
(b)
 FC_PREGNANTWOMEN_2011 990 
(b)
 1 319 375 886 990 
 
Netherlands DNFCS 2007–2010 1 034 906 268 690 1 034 
 
Sweden Riksmaten 2010 807 958 379 854 807 
 
United Kingdom NDNS-RollingProgrammeYears1-3 706 891 266 697 706 
65 to < 75 years Finland FINDIET2012 203 913 314 730 203 
 
France INCA2 153 1 281 408 874 153 
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Age class Country Survey n Average P5 P50 P95 
 
Ireland NANS_2012 77 1 041 345 927 77 
 
Italy INRAN_SCAI_2005_06 157 873 329 736 157 
 
Netherlands DNFCS 2007–2010 82 905 317 712 82 
 
Sweden Riksmaten 2010 168 1 159 373 875 168 
 
United Kingdom NDNS-RollingProgrammeYears1-3 91 1 139 354 839 91 
≥ 75 years France INCA2 44 1 498 
(a) 
740 44 
 
Ireland NANS_2012 43 1 050 
(a) 
922 43 
 
Italy INRAN_SCAI_2005_06 159 816 308 706 159 
 
Sweden Riksmaten 2010 30 1 331 
(a) 
987 30 
 
United Kingdom NDNS-RollingProgrammeYears1-3 83 991 374 771 83 
n, number of individuals; P5, 5th percentile; P50, 50th percentile; P95, 95th percentile. 
DIPP, type 1 Diabetes Prediction and Prevention survey; DNFCS, Dutch National Food Consumption Survey; EsKiMo, Ernährungstudie als KIGGS-Modul; FINDIET, the national dietary 
survey of Finland; INCA, étude Individuelle Nationale de Consommations Alimentaires; INRAN-SCAI, Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione - Studio sui Consumi 
Alimentari in Italia; FC_PREGNANTWOMEN, food consumption of pregnant women in Latvia; NANS, National Adult Nutrition Survey; NDNS, National Diet and Nutrition Survey; NWSSP, 
Nutrition and Wellbeing of Secondary School Pupils; VELS, Verzehrsstudie zur Ermittlung der Lebensmittelaufnahme von Säuglingen und Kleinkindern für die Abschätzung eines akuten 
Toxizitätsrisikos durch Rückstände von Pflanzenschutzmitteln. 
(a): 5th or 95th percentile intakes calculated from fewer than 60 subjects require cautious interpretation, as the results may not be statistically robust (EFSA, 2011b) and, therefore, for these 
dietary surveys/age classes, the 5th and 95th percentile estimates will not be presented in the intake results. 
(b): Pregnant women only. 
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Appendix G.  Minimum and maximum % contribution of different food groups to vitamin A intake in males 
Food groups Age 
1 to < 3 
years 
3 to < 10 
years 
10 to < 18 
years 
18 to < 65 
years 
65 to < 75 
years 
≥ 75 years 
Additives, flavours, baking and processing aids 0 0 0 0 0 0 
Alcoholic beverages 0 0 < 0.1 < 0.1 < 0.1 < 0.1 
Animal and vegetable fats and oils 2.2–9.9 3.2–18.2 4.4–27.3 3.8–21.9 3.1–22.7 3.2–20.3 
Coffee, cocoa, tea and infusions 0–0.1 < 0.1–0.3 < 0.1–0.4 < 0.1–1.6 < 0.1–1.6 0–1.2 
Composite dishes 0.5–11.4 0.6–11.8 0.8–14 0.4–24.3 0.5–19.3 0.3–19.4 
Eggs and egg products 1.2–2.8 1–6.6 0.9–6.3 0.9–4.6 0.6–4.3 1–4.2 
Fish, seafood, amphibians, reptiles and invertebrates 0.1–0.4 0.1–1 0.1–1.1 0.2–1.5 0.6–1.7 0.5–1.4 
Food products for young population 4.9–10.2 < 0.1–1.4 < 0.1 < 0.1 – – 
Fruit and fruit products 0.9–8.9 0.5–3.2 0.4–2.2 0.3–3.4 0.5–4.2 0.4–4 
Fruit and vegetable juices and nectars 0.2– 9.4 1–10.4 1.1–9.1 0.6–5.4 0.3–2.9 0.1–3.2 
Grains and grain-based products 0.3–7.2 0.1–9 0.2–10 3–6.5 2.7–6.1 2.9–6.2 
Human milk < 0.1–3.8 – – – – – 
Legumes, nuts, oilseeds and spices 0.3–1 0.1–0.7 0.1–0.8 0.2–1.3 0.3–0.6 0.4–0.8 
Meat and meat products 0.7–10 5.1–24.5 8.4–16.6 7.4–25.1 14.6–32.5 3.4–38.4 
Milk and dairy products 11.6–31.8 14.7–24.1 16.9–23.8 14–18.3 10.7–16.5 11.7–17.8 
Products for non-standard diets, food imitates and food supplements or 
fortifying agents 
0–0.1 0–0.1 < 0.1–0.2 < 0.1–0.4 < 0.1–0.5 0 
Seasoning, sauces and condiments < 0.1–2.1 < 0.1–6.2 < 0.1–5.7 < 0.1–5.4 < 0.1–3.6 < 0.1–2.6 
Starchy roots or tubers and products thereof, sugar plants < 0.1–0.3 < 0.1–0.9 < 0.1–0.8 < 0.1–0.9 < 0.1–1.4 < 0.1–0.3 
Sugar, confectionery and water-based sweet desserts < 0.1–0.5 0.1–1.1 0.1–1.1 < 0.1–0.5 < 0.1–0.2 < 0.1–0.1 
Vegetables and vegetable products 23.6–58.2 25.3–38.2 19–44.5 15.3–48.5 16.8–52.2 20–49.5 
Water and water-based beverages 0 < 0.1–0.1 < 0.1–0.1 < 0.1–0.1 0 < 0.1–0.1 
“–” means that there was no consumption event of the food group in the age and sex group considered, whereas “0” means that there were some consumption events, but that the food group 
does not contribute to the intake of the nutrient considered, for the age and sex group considered. 
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Appendix H.  Minimum and maximum % contribution of different food groups to vitamin A intake in females 
Food groups   Age    
1 to < 3 
years 
3 to < 10 
years 
10 to < 18 
years 
18 to < 65 
years 
65 to < 75 
years 
≥ 75 
years 
Additives, flavours, baking and processing aids 0 0 0 0 0 0 
Alcoholic beverages 0 0 0 < 0.1–0.2 < 0.1–0.1 0–0.3 
Animal and vegetable fats and oils 2–11.6 3.9–18.4 3.7–25 3.6–18.6 3.3–17.7 3.1–15.9 
Coffee, cocoa, tea and infusions 0–0.1 < 0.1–0.2 < 0.1–0.4 < 0.1–1.4 < 0.1–1.5 < 0.1–0.9 
Composite dishes 0.1–12.8 0.7–11.4 0.4–15.6 0.4–24.7 0.4–16.7 0.3–19.4 
Eggs and egg products 0.8–3.4 1–6.5 0.8–6.4 1–4 0.8–3.8 0.6–4.4 
Fish, seafood, amphibians, reptiles and invertebrates 0.1–0.6 < 0.1–0.7 0.2–1.4 0.2–1.2 0.2–1.2 0.4–0.7 
Food products for young population 4–16.2 < 0.1–0.6 < 0.1–0.1 < 0.1–0.1 – 0.1 
Fruit and fruit products 1–9.2 0.6–2.9 0.5–4.8 0.4–4.5 0.7–5.4 0.6–5.8 
Fruit and vegetable juices and nectars 0.2–8.4 0.9–8.6 1.3–10.9 0.7–4.2 0.7–3.8 0.2–4.9 
Grains and grain-based products 0.4–6.5 0.1–9.1 0.1–9.8 2.7–6 2.9–4.5 2.9–4.4 
Human milk < 0.1 – – – – – 
Legumes, nuts, oilseeds and spices 0.3–0.8 0.1–1 0.2–0.7 0.2–1 0.1–1 0.3–0.6 
Meat and meat products 0.5–5.7 0.9–23.1 4.6–16.1 7.8–29.6 5.7–35.1 4.2–45.8 
Milk and dairy products 13.4–31.3 15.7–25.9 15.9–25.4 11.7–18 8.2–16.8 9.1–18.3 
Products for non-standard diets, food imitates and food supplements or fortifying 
agents 
0–0.3 0–0.1 0–0.3 < 0.1–0.5 0–0.3 0–0.6 
Seasoning, sauces and condiments < 0.1–2.9 < 0.1–6.4 < 0.1–6.1 < 0.1–4.3 < 0.1–2.8 < 0.1–2.5 
Starchy roots or tubers and products thereof, sugar plants < 0.1–1.1 < 0.1–0.8 < 0.1–0.9 0.1–0.8 < 0.1–0.7 < 0.1–0.2 
Sugar, confectionery and water-based sweet desserts < 0.1–0.5 0.2–1.1 < 0.1–1.1 < 0.1–0.5 < 0.1–0.2 < 0.1–0.2 
Vegetables and vegetable products 27.2–59.2 19.6–41.1 21–40.9 22.1–51.7 21.7–55.1 23.8–56.9 
Water and water-based beverages 0 < 0.1–0.1 0–0.1 < 0.1–0.1 0 < 0.1 
 “–” means that there was no consumption event of the food group in the age and sex group considered, whereas “0” means that there were some consumption events, but that the food group 
does not contribute to the intake of the nutrient considered, for the age and sex group considered. 
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ABBREVIATIONS 
Afssa Agence française de sécurité sanitaire des aliments 
AI Adequate Intake 
AR Average Requirement 
BCMO1 β,β-carotene-15,15′-monooxygenase 1 
BMD bone mineral density 
CI confidence interval 
COMA Committee on Medical Aspects of Food Policy 
CRABP cellular retinoic acid-binding protein 
CRBP cellular retinol-binding protein 
CV coefficient of variation 
CYP cytochrome P450 
D-A-CH Deutschland-Austria-Confoederatio Helvetica 
DGAT acyl-CoA:retinol acyltransferase 
DH UK Department of Health 
DIPP type 1 Diabetes Prediction and Prevention survey 
DNFCS Dutch National Food Consumption Survey  
DRD deuterated–retinol–dilution 
DRV Dietary Reference Value  
EAR Estimated Average Requirement 
EFSA European Food Safety Authority 
EsKiMo Ernährungstudie als KIGGS-Modul 
EU European Union 
FABP fatty acid-binding protein 
FC_PREGNANTWOMEN food consumption of pregnant women in Latvia 
FAO Food and Agriculture Organization of the United Nations 
FINDIET the national dietary survey of Finland 
FFQ food frequency questionnaire 
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HDL high-density lipoprotein 
HR hazard ratio 
IFN interferon 
IL interleukin 
INCA étude Individuelle Nationale de Consommations Alimentaires 
INRAN-SCAI Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione - Studio 
sui Consumi Alimentari in Italia 
IOM US Institute of Medicine of the National Academy of Sciences 
LDL low-density lipoprotein 
LRAT lecithin:retinol acyltransferase 
NANS National Adult Nutrition Survey 
NDNS UK National Diet and Nutrition Survey 
NHANES III US Third National Health and Nutrition Examination Survey 
NNR Nordic Nutrition Recommendations 
NPC Nutritional Prevention of Cancer 
NWSSP Nutrition and Wellbeing of Secondary School Pupils 
PPAR peroxisome proliferator-activated receptor 
PRI Population Reference Intake 
RAE retinol activity equivalent 
RAR retinoic acid receptor 
RBP retinol-binding protein 
RDA Recommended Dietary Allowance 
RDR relative dose response 
RE retinol equivalent 
RID retinol isotope dilution 
RNI Reference Nutrient Intake 
RXR retinoic X receptor 
SACN UK Scientific Advisory Committee on Nutrition 
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SCF Scientific Committee for Food 
SD standard deviation 
SE standard error 
SEM standard error of the mean 
SR-B scavenger receptor class B 
UK United Kingdom 
UL Tolerable Upper Intake Level 
UNU United Nations University 
US United States 
VELS Verzehrsstudie zur Ermittlung der Lebensmittelaufnahme von 
Säuglingen und Kleinkindern für die Abschätzung eines akuten 
Toxizitätsrisikos durch Rückstände von Pflanzenschutzmitteln 
VLDL very low-density lipoprotein 
WHAS Women’s Health and Ageing Study 
WHO World Health Organization 
 
